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Chapter 1. 
Introduction 

Animal models of glomerulonephritis, either spontaneously occurring or induced by 
passive or active immunization, have since long been used to define the role of 
humoral and cellular mediators of glomerular damage and proteinuria (1). One of the 
best known models of experimental glomerulonephritis is the nephrotoxic nephritis, 
induced by the administration of antibodies against renal glomerular basement 
membrane (GBM) (2,3). The extent of the disease proved to be dependent on the 
animal species, the type of antibody used, the amount of antibody administered, and 
the host response to the administered antibodies (1). The induction of proteinuria and 
the morphological damage is caused by the activation of several inflammatory 
mediators and by the accumulation of inflammatory cells in the glomeruli after 
binding of the antibodies to the GBM (4). This nephrotoxic, or passive anti-GBM 
nephritis can be divided in two phases, an early or heterologous phase and a second 
or autologous phase. The heterologous phase comprises the early stage of the disease 
in which the administered heterologous antibodies, fixed to the GBM, determine the 
renal damage. The second or autologous phase is defined by the immune response of 
the host to the heterologous antibodies fixed to the GBM. 
The humoral and cellular mediators, which are involved in the morphological 
damage and proteinuria in experimental anti-GBM nephritis differ in the various 
animal species studied. In the guinea pig, administration of anti-GBM antibodies 
leads to a complement and polymorphonuclear (PMN) independent, transient 
proteinuria, without visible morphological damage (5). In other animal species, e.g. 
the rabbit and the rat, complement activation after antibody binding to the GBM is an 
essential event (6-8), which generates potent chemoattractants such as C5a. Although 
complement activation alone can under certain circumstances be sufficient to cause 
proteinuria in the rabbit or the rat (9-11), the most prominent role of complement is 
to mediate the influx of PMN and, in some species, of mononuclear cells (6,12,13). 
Due to the generation of chemotactically active substances (e.g. leukotriene B4, C5a, 
platelet activating factor, interleukin 8), PMN accumulate in the glomerular tuft. 
PMN recruitment and attachment to glomerular endothelial cells is a sequential 
process that is regulated through the coordinated interactions of inflammatory 
mediators and adhesion molecules (14,15). This results in the detachment of the 
endothelial lining of the GBM and exposure of the GBM to the invading PMN (7). 
The PMN possess several potent proteolytic enzymes e.g. neutral, acid, basic, and 
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cysteine proteinases (16), which are able to digest GBM (17). Other mediators of 
inflammation such as reactive oxygen metabolites (ROM) are not only capable of 
directly damaging the GBM and the endothelial cells, but can also inactivate the 
endogenous inhibitors of proteinases, thereby enhancing the proteolytic activity of 
the leukocytic proteinases (18). 
A definite role of monocytes and macrophages in the pathogenesis of anti-GBM 
nephritis has been demonstrated in the autologous phase of rat and rabbit (19-21). 
The involvement of this cell type in the heterologous phase remains, however, 
controversial (21,22). Lymphocytes have also been implicated in the development of 
morphological damage in the early phase of anti-GBM nephritis in rats, probably as a 
manifestation of a delayed hypersensitivity type reaction (23-25). 
Platelets and fibrin deposits are often prominently present in glomeruli of animals 
with experimental anti-GBM nephritis. Although platelets are potent effectors of 
inflammation that have been shown to play a role in several models of 
glomerulonephritis (26), there are conflicting reports on the role of platelets in the 
heterologous phase in the rat and the rabbit (27-29). Fibrin deposits, the formation of 
which is promoted by procoagulant factors produced by endothelial cells under the 
influence of activated PMN, have been reported to be important in the mediation of 
the formation of crescents in the autologous phase of rabbits (30-32); their 
involvement in the induction of proteinuria in the heterologous phase of anti-GBM 
nephritis has only been reported in one study in the rat (33). 
Finally, the role of resident glomerular cells in anti-GBM nephritis has not been 
studied in detail and remains to be elucidated. The different pathways that have been 
shown to provoke albuminuria after the i.v. administration of anti-GBM antibodies 
are summarized in Figure 1 (modified from Couser et al. (34)). 
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Figure 1. Activation pathways of inflammatory mediator systems in the heterologous 
phase of anti-GBM nephritis. 
The heterologous phase of anti-GBM nephritis has mostly been studied in rats and 
rabbits and is characterized by an immediate binding of the administered antibodies 
to the GBM in a linear pattern, followed by deposition of complement at the same 
site. This activation of complement is followed by the influx of PMN within 15-30 
minutes after the induction of the nephritis. By electron microscopy (EM), damage to 
the endothelial cells and adherence of PMN to the denuded GBM is readily visible. 
There is also some accumulation of platelets in the glomerular capillary lumina, 
visible as early as two hours after the administration of the antibodies, although this 
is far less prominent than the PMN influx. After 24 hours the PMN influx has 
completely disappeared, whereas extensive morphological damage can be observed, 
primarily consisting of endothelial cell destruction and intravascular coagulation. 
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Crescent formation can sometimes be observed, although to a much lesser extent 
than in the autologous phase, especially in rabbits. Proteinuria, which is progressive, 
starts about six hours after the induction of the nephritis, at the time when the 
number of PMN in the glomeruli is already decreasing. Although in rabbits the 
heterologous phase is not dependent on monocytes/macrophages (21), these cells are 
believed to contribute to some extent to the glomerular damage in rats after the initial 
attack of PMN (22). 
Until recently, the heterologous phase of anti-GBM nephritis in the mouse had not 
been studied extensively because it proved to be very difficult to induce reproducible 
glomerular damage in this animal species (35). We have successfully induced a 
reproducible, dose dependent albuminuria in different strains of mice, using goat or 
rabbit anti-mouse GBM antibody (36). This enabled us to study in detail the role of 
several mediator systems responsible for the morphological lesions and albuminuria 
in this animal species. In contrast to the heterologous phase of anti-GBM nephritis in 
rats and rabbits we found that the albuminuria and glomerular damage in mice, one 
day after the administration of the anti-GBM antibody, was solely dependent on the 
presence of PMN (37). No glomerular influx of monocytes/macrophages or 
lymphocytes could be detected during the first 24 hours. Complement, although it 
was transiently deposited in the glomeruli, did not appear to play an mediatory role 
in the pathogenesis of the model (38). In addition, using a specific mouse strain 
(C57BL/6J, bg/bg, beige mouse), congenitally deficient for the neutral proteinases 
elastase and cathepsin G, we were able to demonstrate that the albuminuria, that 
developed immediately after the induction of the nephritis, was entirely dependent on 
the leukocytic elastase and/or cathepsin G activity of the PMN and not on other 
mediators like ROM (39). Despite a glomerular influx and morphological damage 
comparable to that occurring in congenie, non-deficient mice (C57BL/6J, i-/+), no 
albuminuria developed in the beige mice. From these studies it appeared that the 
factors responsible for the protein leakage in this model were different from those 
causing the morphological damage: we found a striking difference in albuminuria 
between beige and control mice, while the damage to the glomerular endothelial cells 
was the same. Our hypothesis was that ROM are responsible for the endothelial 
damage, possibly in addition to other factors, but that they cannot cause proteinuria 
in this model. A cytotoxic action of ROM on endothelial cells in vitro has been 
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demonstrated (40). On the other hand, it has been shown in ex vivo perfusions of rat 
kidneys, that leukocytic proteinases can cause albuminuria in the absence of 
histological damage (41). 
The aim of the present study was to test the abovementioned hypothesis further. 
During our initial experiments it appeared that the mechanisms involved in the 
heterologous phase were more complicated than we had originally assumed. Within 
the heterologous phase we could distinguish an early and a late period in which 
different mediators seemed to play a role. These findings made a separate study of 
these periods necessary. First, we tried to establish firmly that the lack of 
albuminuria seen in the early heterologous phase in beige mice was due to an 
intrinsic defect of beige PMN and not to local factors (chapter 2). Our next aim was 
to describe the late heterologous phase (days 2-5) in beige mice and to study the 
mediators involved, i.e. PMN, macrophages, complement, ROM, platelets, and fibrin 
(chapters 3 and 4). We examined the role of macrophages by using treatment with 
dichloromethylene bisphosphonate containing liposomes as a method of macrophage 
depletion (chapter 5). Finally, we devised a reproducible model of the accelerated 
autologous phase in mice (chapter 6), to study the role of macrophages and 
macrophage related cytokines, CSF-1 and RANTES, in this phase (chapter 7). 
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Chapter 2 
Lack of albuminuria in the early heterologous phase of anti-GBM 
nephritis in beige mice 
G.W. Feith, K.J.M. Assmann, M.J.J.T. Bogman, A.P.M. van Gompel, J. Schalkwijk, 
and R.A.P. Koene 
Kidney International 1993,43 824-827 

Lack of albuminuria in the early heterologous phase of 
anti-GBM nephritis in beige mice 
G E E R T W. F E I T H , K A R E L J .M. A S S M A N N , M. J O S É J.T. B O G M A N , 
A L P H O N S P.M. V A N G O M P E L , J O O S T S C H A L K W I J K , and R O B E R T A . P . K O E N E 
Departments of Pathology, Dermatology and Internal Medicine, Division of Nephrology, University Hospital Nijmegen, The Netherlands 
Lack of albuminuria In the early heterologous phase of anti-GBM 
nephritis In beige mice. Passive and-glomcrular basement membrane 
(GBM) ncphnlts in the mouse is accompanied by acute massive 
albuminuria in the early heterologous phase As we have previously 
shown, this albuminuria does not occur in the beige mutant of the 
07BL/6J strain which is deficient for the leukocytic neutral proteinases 
claslase and cathepstn G To address the question whether an intrinsic 
defect in the polymorphonuclear granulocyte (PMN) or local factors in 
the beige kidney are responsible for the lack of albuminuria in the beige 
mouse strain, we conducted reciprocal bone marrow transplantations 
(DMT) in beige and congenie control mice Injection of anti-GBM 
antibody resulted in only slight albuminuria (89 ± 47 μβ/Ι8 hours. N = 
6) in normal (that is, non irradiated, non reconstituted) beige mice By 
contrast, in beige mice, reconstituted with bone marrow (BM) from 
control mice acute albuminuria developed (3032 ± 1408 Mg/18 hours, N 
= 8), to a degree comparable to that in non-irradiated control mice (44II 
± 3405 μ&νΐ8 hours, N = 6. Ρ < 0 01) Albuminuria in control mice, 
reconstituted with beige BM, was in the range of the normal beige mice 
(112 ± 55 ^g/18 hours, N = 9) Reconstitution with syngeneic bone 
marrow demonstrated that BMT by itself did not influence the level of 
albuminuria AH mice showed similar morphological lesions, with 
comparable influx of PMN in the glomeruli two hours after antibody 
injection Elaslase activities of PMN extracts in BMT groups were not 
different from those in donor mice We conclude that the absence of 
albuminuria in beige mice is caused by an intrinsic defect in leukocytic 
neutral proteinase activity 
The experimental model of passive anti-GBM nephritis, 
induced by ι ν injection of anti-GBM antibody, has been 
extensively studied in various species [reviewed in I] Espe­
cially the studies of the early heterologous phase of this model 
have demonstrated the existence of several immunologic path­
ways involved in glomerular damage and increased glomerular 
permeability [1-3] The functional and morphological alter­
ations seen immediately after the ι ν injection of heterologous 
antibodies can be brought about by the binding of the antibody 
to the GBM alone [4, 5], by activation of the complement 
system [6] or by PMN attracted by complement factors [1,3] 
The latter pathway, in which both complement and PMN are 
necessary for the mediation of glomerular damage, is the most 
prominent mechanism leading to albuminuria in nearly all 
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species studied in the early heterologous phase of this model [1, 
7] Using a munne model we found an additional pathway 
leading to glomerular damage, that apparently is not operative 
in other animal species, and is dependent on the presence of 
PMN alone, without an essential role for complement [8, 9] 
Such a mechanism has only been reported in the later stage of 
nephritis in this model, the so-called autologous phase, that is 
effected by the immune response of the host to the injected 
antibodies [10, 11) When anti-GBM antibody was injected in 
mutant C57BL/6J, bg/bg (beige) mice, which are known to have 
a deficiency for the leukocytic neutral proteinases elastase and 
cathepsm G [12], we found that the acute albuminuria in the 
early phase did not occur, despite an influx of PMN in the 
glomeruli comparable to that in the congenie (CS7BL/6J, +/+) 
controls, and despite similar binding of antibody to the GBM 
[13] This suggested that in ποπ-defìcient mice the early albu-
mi nuna is caused by the leukocytic neutral proteinases, and not 
by other inflammatory mediators such as reactive oxygen 
metabolites which are also released from the activated PMN 
[13] 
In the present study we offer definitive evidence that the lack 
of albuminuria in the beige mice in the early phase of the 
passive anti-GBM nephritis is due to the intrinsic cellular defect 
of beige PMN By performing reciprocal BMT in beige and 
control mice, we demonstrated that the acute albuminuria in the 
munne anti-GBM model is indeed dependent on (he presence of 
functionally intact PMN, with normal elastase and cathepsm G 
activity 
Methods 
Animals 
C57BI/6J, +/+ (control) mice were originally obtained from 
Harlan Olac (Bicester, Oxon, England) and were kept in our 
laboratory by continuous brother sister matings C57B1/6J, 
bg/bg (beige) were bought from the Jackson Laboratory (Bar 
Harbor, Maine, USA) Only male mice were used at ages of 
three to four months weighing more than 20 g The enzymatic 
deficiency present in the beige mice was assessed by testing the 
enzyme activity in PMN obtained from the peritoneal cavity 
(see below) Random bred Swiss mice were purchased from the 
Central Institute for the Breeding of Laboratory Animals (TNO. 
¿eist. The Netherlands) NZW rabbits, used for the preparation 
of the antiserum, were bought from a local breeder 
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Ann-mouse GBM antibodies 
The rabbit anti-mouse GBM (RaMGBM) antibodies were 
prepared, purified, and assessed for punty and spec ι fit y as 
described before [9, 14] The immunoglobulin concentration of 
the final preparation, as determined by radial immunodiffusion 
[15] was 25 mg/ml 
Induction of antt GBM nephritis 
Anti-GBM nephritis was induced by ι ν injection of 7 5 mg of 
RaMGBM as described previously [14] The mice that under­
went BMT received this injection at day 49 after BMT Albu­
minuria was determined in unne samples obtained from six to 
24 hours after ι ν injection of RaMGBM, during which time the 
animals were placed in individual metabolic cages [14] The 
unnary albumin concentrations were measured by radial immu­
nodiffusion using goat anti-mouse albumin antibodies [14, 15] 
Total body irradiation and bone marrow transplantation 
One day before BMT, lethal total body irradiation (TBI) was 
given in a single dose of 10 Gy at a dose rate of 2 Gy/min with 
a 13 MeV electron beam from a linear accelerator (CGR 
Saturne. Bue, France) Immediately afterwards the mice were 
placed m laminar flow housing for seven weeks, with free 
access to normal food and drinking water containing Neomycin 
(100 mg/hter) and Polymyxin В (40 mg/liter) [16] The mice 
received BM cell suspensions obtained from the femora of 
untreated donor mice obtained under strictly aseptic condi­
tions Recipient mice were reconstituted via the lateral tail vein 
with approximately 3 x IO7 BM cells, of which more than 90% 
were viable, as assessed by Trypan blue dye exclusion 
Determination ofelastase activity in peritoneal PMN 
Mouse peritoneal PMN were harvested 24 hours after ι ρ 
injection of 0 5 ml IFA (Difco Laboratories, Detroit. Michigan, 
USA), by la vagi ng the peritoneal cavity with 10 ml of cold 
saline containing 10 U of heparin The cell suspension, which 
contained more than 85% PMN, was washed three times in cold 
saline and resuspended in a solution containing 0 5 м NaCl, 
0 4% cetnmide (Sigma Chemical Co , St Louis, Missouri, 
USA), 0 1 M Tns, pH 8 0 at a concentration of 1 x I07 PMN/ml 
The cells were disrupted by somcation (3 bursts of 10 sec at 
setting 50%, with 30 sec pause and cooling on melting ice), and 
the homogenate was centnfuged at 13.000 g, for 10 minutes at 
4°C The elastase activity in the supernatant was measured 
fluonmetncally using methoxy-succinyl-alanyl alanyl prolyl-
valyl-amidomethylcoumarm (Bachern, Bubendorf, Switzer­
land) as a substrate [17] The enzyme content was expressed as 
pkatal per 10* cells, 1 pKatal being the amount of enzyme that 
converts 1 pmole of substrate per second under the given assay 
conditions 
Histology and immunofluorescence 
Three days after the induction of the nephritis, the mite were 
killed, and the kidneys were removed immediately after perito­
neal lavage Tissue fragments were fixed in Bourn's solution, 
dehydrated and embedded in paraplast (Amstelstad В V , Am­
sterdam, The Netherlands), and 4 μία sections were stained 
with periodic acid Schiff and silver methenamine For immuno­
fluorescence (IF), kidney fragments were snap frozen in liquid 
Table 1 Elastase activity of peritoneal PMN, after reciprocal BMT 
in C57BL/6J bg/bg and C57BU6J +/+ mice 
Elastase activity" 
Group 
A 
В 
С 
D 
E 
F 
Recipient 
bg/bg 
bg/bg 
bg/bg 
+/+ 
+/+ 
+ H-
<N) 
(6) 
(8) 
(7) 
(6) 
(8) 
O) 
Donor 
_" 
bg/bg 
+/+ 
+/+ 
bg/bg 
* Mean ± SD 
ь
 Non irradiated mice 
nitrogen, and 2 μτη cryostat sections were stained with FITC-
labeled swine anti-rabbit immunoglobulin (DAKO, Copen­
hagen, Denmark), rabbit anti-human fibrinogen immunoglobu­
lin that crossreacts with mouse fibrinogen (DAKO), sheep 
anti-mouse immunoglobulin (Cappel Laboratories, West 
Chester, Pennsylvania, USA), and goat anti-mouse C3 immu­
noglobulin (Nordic, Tilburg, The Netherlands) The sections 
were examined in a Leitz fluorescence microscope equipped 
with a Ploemopak epullumination and the staining intensity was 
recorded semiquantitative^ (on a scale from 0 to 4 + ) as 
described before [14] 
Statistical analysts 
For statistical analysis, Wilcoxon's rank sum test was used Ρ 
values < 0 05 were considered significant All values arc ex­
pressed as means ± SD 
Results 
Bone marrow transplantation and total body irradiation 
In general, no untoward effects were observed after BMT 
Only two mice died after BM reconstitution and before the 
induction of the nephritis All mice tolerated the induction of 
the nephritis and the immediate period thereafter well The 
adequacy of the irradiation was confirmed in mice which 
underwent TBI without concomitant BMT (N = 9) all animals 
died within two weeks The elastase activity in the PMN 
extracts of the different BMT groups clearly correlated with the 
donor lineage of the BM (Table 1), demonstrating that engraft -
ment had been successful in all BMT groups The elastase 
activity in mice with either the original or the reconstituted 
PMN of beige origin was about 4% of the values obtained in 
mice with functionally normal PMN 
Albuminuria 
The albuminuna at day I after injection of anti-GBM anti 
bodies in groups of beige and control mice, with or without 
reciprocal BMT, is shown in Table 2 BMT as such had no 
influence on the physiologic albuminuria, which in all groups 
remained within the normal range (for beige mice 49 ± 17 /ig/1 8 
hours, and for control mice 38 ± 24 μ£/18 hours, as determined 
in groups of 30 mice per strain) Injection of anti-GBM antibody 
in beige mice caused only a marginal, non-significant increase in 
the albuminuria, and the same results were seen in beige mice 
reconstituted with beige BM cells after TBI By contrast, beige 
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ТаЫ* 2. Albuminuria in C57BU6J, bg/bg and C57BU6J +/+ mice 
after reciprocal В MT seven days before and 6 to 24 hours afler 
injection of rabbit anti mouse GBM antibodies (RaMGBM) 
Albuminuria ßg/l8 hr* 
before after 
Group Recipient (Л0 Donor RaMGBM RaMGBM 
л 
в 
с D 
E 
F 
bg/bg 
bg/bg 
bg/bg 
+/+ 
+/+ 
+/+ 
(6) 
(8) 
(8) 
(6) 
(9) 
(9) 
ь 
bg/bg 
+/+ 
+/+ 
bg/bg 
32 î 8 
J4 ± 9 
45 ± 12 
23 ±35 
33 ± 5 
28 ± 8 
" Mean ± SD 
ь
 Non-irradiated mice 
e
 Ρ < 0 01 as compared to group A 
J
 NS as compared to group D 
β
 Ρ < 0 Ol as compared to group F 
mice reconstituted with BM cells from the control strain devel­
oped a marked albuminuria after injection of RaMGBM, to a 
degree that was only slightly lower than that in non-reconsti­
tuted control mice Conversely, albuminuria in control C57BL/ 
67, +/+ mice reconstituted with beige BM, was in the range of 
that in untreated beige mice 
Immunohistology 
From earlier studies we know that after injection of anti-
GBM antibody, the beige strain shows a prominent influx of 
PMN in the glomerulus, maximal two hours after injection, and 
identical to that in the congenie controls Furthermore, the 
glomerular acumulation of PMN preceded damage to endothe­
lial cells in both strains [13} In a separate study we found that 
TBI with BMT had no influence on the linear binding of the 
antibody to the GBM, nor on the fine granular deposition of C3 
(data not shown) Therefore, we did not study these aspects in 
the present groups, but kept the mice alive for assessment of 
effective engraft ment of the BM by determination of the elas-
tase activity of the peritoneal PMN at day 3 The animals were 
sacrificed immediately afterwards for (immuno)histologic ex­
amination of the kidneys At this time, a strong linear binding of 
RaMGBM to the GBM was seen, independent of strain or 
BMT, and a few fine granules of C3 were observed along the 
GBM and in the mesangium in all groups Several glomeruli 
contained deposits of fibnn in capillary lumina and along the 
capillary wall By light microscopy, we found in all experimen­
tal groups many glomeruli with overt necrosis of one or more 
glomerular segments, accompanied by only sporadical intra-
capillary PMN In the non-affected glomerular loops no leuko­
cytes were found 
Discussion 
Beige mice do not develop an acute albuminuria in the early 
heterologous phase of the passive anti-GBM nephritis, despite a 
glomerular PMN influx and morphological endothelial damage 
comparable to that in normal, congenie controls [13] We 
proposed that this lack of albuminuria in beige mice was due to 
their deficiency of neutral proteinase activity in PMN, as these 
proteinases are known to be potent mediators of tissue injury 
[18] and are able to degrade extracellular matnees in vi\o [19, 
20] and m \itro [21. 22] Other possible intrinsic deficiencies of 
the PMN in beige mice, such as their adhesive properties to 
extracellular matnees, can be ruled out, because beige PMN 
adhered m the same way to the inner side of the GBM as their 
normal counterparts two hours after injection of the anti-GBM 
antibody To prove our hypothesis, and to exclude unknown 
local tissue or systemic humoral factors inherent to the beige 
mutation, reconstitution experiments with pure suspensions of 
non-deficient PMN were required Simple transfer experiments 
failed, however, because of the rapid elimination of PMN from 
the circulation after the transfer, even when large numbers of 
PMN were given repeatedly We therefore decided to reconsti­
tute PMN by reciprocal BMT The success of this procedure in 
beige and congenie control mice was confirmed by the deter­
minations of elastase activity in peritoneal PMN homogenates, 
obtained at nine weeks after BMT (Table I) 
The finding that albuminuria develops in beige mice reconsti 
tuted with normal BM, as well as the lack of albuminuria in 
control mice after reconstitution with beige BM, clearly dem 
onstrates that the enhanced glomerular permeability in this 
munne model is dependent on BM derived cells with functional 
neutral proteinase activity Beige mice, which have many 
features in common with the recessively inherited Chédiak 
Higashi syndrome in humans, show, apart from the enzymatic 
deficiency of the PMN, other abnormalities, such as platelet 
storage pool disease resulting in prolonged bleeding, and a 
defective natural killer cell function [23] Theoretically, there-
fore, bone marrow cells other than PMN, such as monocytes, 
lymphocytes and platelets could be responsible for a different 
reaction to injection of anti-GBM antibody There are several 
arguments marking the PMN and not other BM cells as the 
mediators of the GBM damage First, in the beige mutants the 
only cell known to be deficient for neutral proteinase activity is 
the mature PMN Monocytes and lymphocytes of beige mice 
have a neutral proteinase activity which is similar to that of 
congenie control mice and (his activity is quantitatively only a 
small fraction of that in PMN of non deficient C57BL/6J, + /+ 
mice [12] The same holds for platelets [12] The defect in the 
beige PMN is only present in the more mature stages of the 
cells Beige PMN precursors up to and including the metamy-
elocyte stage have a normal proteinase activity [24] Second, 
injection of anti GBM antibodies in the mice did not result in an 
increase of monocytes or lymphocytes in the glomeruli at any 
time during the first 24 hours, that is during the period in which 
the albuminuria was measured, and during which the PMN 
influx was observed This was studied both histologically and 
ultras I ructurally (unpublished data) Third, platelets may theo-
retically be involved in the induction of anti-GBM nephritis, by 
release of canonic proteins from their alpha granules, resulting 
in a loss of anionic charges in the GBM and subsequent 
increased glomerular permeability for proteins [25] However, 
beige mice have normal alpha granules [26] 
There are several points of interest calling for further study 
First, we have observed previously that in the beige mice the 
injection of anti-GBM antibody prevented the early albumin-
uria, but not the damage to the endothelial cells [13] Since 
there is no difference in the generation of reactive oxygen 
metabolites between the beige mice and the normal controls 
[13], we assumed that reactive oxygen metabolites were in-
volved in the endothelial cell destruction, independently of the 
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presence of proteinases in the PMN Another interesting point 
is the recent finding that the enzymatic deficiency in the beige 
PMN is not due io an absence of genetic expression for neutral 
proteinases, but is caused by intracellular formation of specific 
proteinase inhibitors during the later stages of maturation [27] 
These inhibitors form intracellular covalent complexes with the 
active sites of elastase and cathepsin G, thus inhibiting the 
enzymatic activity (27) Characterization and production of 
these inhibitors may be useful in future studies on the role of 
leukocytic neutral proteinases in tissue damage 
In conclusion, we have demonstrated ш this study that the 
early albumin una in the heterologous phase of anti-GBM ne­
phritis in the mouse depends on the presence of enzymatically 
competent PMN, and that the absence of albuminuria in the 
beige strain is not due to local tissue factors or unknown 
humoral factors, but is directly related to the deficiency of the 
beige PMN in functional elastase and cathepsin G 
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Abstract 
Background After the injection of rabbit anti-mouse 
glomerular basement membrane (GBM ) antibody into 
normal C57BL/6J mice severe albuminuria develops, 
which reaches a peak at 24 h This early albuminuria 
is dependent on polymorphonuclear granulocytes 
( PMN ) and is completely absent in the congenie beige 
mutant strain (C57BL/6J, bg bg). which is genetically 
deficient in leukocytic neutral proteinase activity We 
now studied the development of anti-GBM nephritis 
in beige mice during the later heterologous phase 
Methods In untreated beige mice we assessed the 
albuminuria and glomerular lesions on days I 5 after 
ι ν injection of anlt GBM antibody Secondly, effector 
mechanisms involved in the later days of the heterolog­
ous phase were studied by substitution of whole anli-
GBM antibodies by F(ab )2 fragments, by leukocyte 
depletion (total body irradiation) scavenging of react­
ive oxygen metabolites (dimethylsulfoxide treatment), 
and complement depletion (cobra venom factor 
treatment) 
Results In the later part of the heterologous phase 
(days 2-5), when there is still no sign of autologous 
antibody formation, ι ν injection of anti-GBM anti­
bodies in beige mice induces nephritis with gradually 
increasing albuminuria, that reaches levels similar to 
those in non deficient congenie controls by day 3 This 
late albuminuria did not occur after injection of Hab h 
fragments of the antibody, could be prevented by 
leukocyte depletion, and was greatly reduced by treat­
ment with dimethylsulfoxide, a scavenger of hydroxyl 
radicals The late albuminuria was not influenced by 
complement depletion with cobra venom factor 
Histologic and immunohistologic studies gave no 
indication for a role of glomerular macrophages or 
lymphocytes 
Conclusions The heterologous phase in murine anti-
GBM nephritis is a biphasic process, with sequential 
involvement of different and independent mediating 
Cormpondune and offprint requests to R A P Koene Department 
of Nephrology University Hospital Nijmegen PO Bon 9101 6500 
HB Nijmegen The Netherlands 
systems both phases are PMN-dependent, but only 
the early albuminuria depends on leukocytic neutral 
proteinase activity, whereas the albuminuria and the 
glomerular damage at later days are effected by reactive 
oxygen metabolites, most probably originating from 
PMN accumulating in the glomerulus 
Kev words: albuminuria, anti-GBM nephritis, mice, 
monocytes, neutrophils 
Introduction 
The immunologic mediation of proteinuria tn immune 
complex nephritis has been studied in a large number 
of experimental models [reviewed in 1 and 2] Among 
these the model of passive anti-glomerular basement 
membrane (GBM ) nephritis, or nephrotoxic nephritis, 
has been most extensively studied This nephritis, 
induced by ι ν injection of heterologous anti-GBM 
antibodies [1,3], has been studied in different species 
and has revealed that different immunological path­
ways may lead to glomerular damage The increased 
glomerular permeability and the morphological 
changes can be induced by the binding of antibody to 
the GBM alone [4,5] by complement activation [6] 
or by polymorphonuclear granulocytes (PMN) with 
or without accessory involvement of complement 
[7-9] In most species, the first histological reaction 
consists of glomerular accumulation of PMN, that is 
maximal at 2 h after the injection of the anti-GBM 
antibodies, and leads to endothelial damage enhanced 
glomerular permeability, necrosis, and fibrin deposition 
[1,10] The resulting albuminuria is maximal in the 
first 24 h, and persists although to a lesser degree, in 
the following days Six to 7 days after induction of the 
nephritis the host response to the heterologous anti­
bodies initiates the autologous phase, immunohislolog-
ically visible as linear deposition of mouse antibodies 
to the GBM-bound foreign immunoglobulin (Ig), and 
accompanied with histological damage, further increase 
t 1996 European Dialvsis and Transplant Association European Renal Association 
29 
of the existing albuminuria, and eventually chronic 
renal disease. 
We have described a murine model of passive anti-
GBM nephritis with massive albuminuria (11), that is 
PMN dependent but complement independent [12,13]. 
In C57BL/6J, bg/bg (beige) mice, deficient for the 
leukocytic neutral proteinases elastase and cathepsin G 
[14]. we found that the early albuminuria in the first 
24 h was absent, despite unimpaired PMN influx at 
2 h. After transplantation with normal bone marrow, 
leading to a circulating PMN pool with normal neutral 
proteinase activity, the early albuminuria in the beige 
mice became comparable to that in normal 
C57BL/6J mice [15,16]. In the present study we tested 
the effect of elastase and cathepsin G deficiency on the 
sequence of events in the later days of the heterologous 
phase, i.e. days 2-5. 
Methods 
Animals 
C57BL/6J, bg/bg (beige) mice were bought from the 
Jackson Laboratory (Bar Harbor, Maine, USA). Congenie 
C57BL/6J. + / + (control) mice were originally obtained 
from Harlan Olac (Bicester. Oxon, UK) and were kept in 
our laboratory by continuous brother-sister matings. For all 
experiments we used 3-6 months old animals weighing 
20-25 g. wilh age and sex matched controls. New Zealand 
White rabbits, used for the preparation of the anti-GBM 
antibodies, were bought from a local breeder. 
Anti-mouse GBM antibodies andF(ab')2 fragments 
A first batch of RaMGBM (I), used for the study of the 
urinary albumin excretion and the glomerular damage, and 
for the quantitation of the binding of RaMGBM to the 
glomeruli in beige and control mice, was prepared, purified, 
and assessed for purity and specifity as described before 
[11,131. The Ig concentration of the final preparation, deter­
mined by radial immunodiffusion [17] was 25 mg/ml. A 
second batch of RaMGBM (II), prepared in the same way, 
was used for the studies of leukocyte depletion, complement 
depletion, antioxidant treatment with DMSO, and the effects 
of injection of F(ab')2 fragments in beige mice. The final lg 
concentration of this antiserum was 15 mg/ml. 
F(ab')2 fragments from whole anti-GBM antibodies were 
prepared by digestion with pepsin as described previously 
[18]. Briefly, RaMGBM. containing 15 mg Ig ml, was dia-
lysed for 4 h at room temperature against 0.1 M sodium 
acetate buffer, pH 4.5. Pepsin was added at a ratio of 
4 mg/100 mg Ig. Digestion was allowed to proceed at 37 С 
for 20 h, and the precipitate was removed by cent rifuga tion 
(600 g, 10 min). The supernatant was neutralized in TRIS 
buffer, pH 7.4, concentrated and fractionated by gel chroma­
tography on a 80 χ 2 cm Ultrogel ACA-44 column 
(Pharmacia, Uppsala, Sweden) with a separation range 
10-130 kDa. The mol. wt of the collected F(ab')2 fragments, 
was approximately half the mol. wt of the undigested Ig, as 
shown by SDS-PAGE analysis with simultaneous application 
of marker proteins. The fraction containing F(ab')2 frag­
ments was concentrated to a final concentration of 42 mg/ml 
as measured in a Lowry assay ( 19). 
Glomerular antibody binding and quantitation 
Glomerular binding of RaMGBM was assessed by indirect 
immunofluorescence (IF) using FITOIabeled swine anti-
rabbit Ig (DAKO. Copenhagen. Denmark) as a second 
antibody. Both batches of RaMGBM and the F(ab')* frag­
ments bound in a linear fashion to the GBM and tubular 
basement membrane of normal mouse kidneys. For quantita­
tion of the glomerular binding undigested RaMGBM Ig. 
F(ab')2 fragments, and normal rabbit Ig were labeled with l 2 Sl, using Iodo beads (Pierce Chemical Co.. Rockford, 
Illinois. USA) as a coupling reagent (20) to a specific activity 
of 0.02-0.03 mCi/mg protein. Free l 2 5 I was removed by G25 
Sephadex chromatography (Pharmacia. Uppsala, Sweden), 
and unlabeled lg or F(ab')2 fragments were added to obtain 
the desired concentration of 15 mg/ml. The specific activity 
of the preparations was measured immediately before i.v. 
injection. The in vivo glomerular binding of intact RaMGBM 
Ig. F(ab')2 fragments, and normal rabbit Ig was measured 
according to the method of Gauthier and Mannik [21]. with 
modifications as described previously [12]. Briefly. 1 h after 
i.v. injection of the l 2 S I labeled antibodies. F(ab')2 fragments, 
or normal rabbit Ig, the mice were anaesthetized with sodium 
pentobarbital (Narcovet, Apharma B.V.. Arnhem. The 
Netherlands). Via a cannula inserted in the abdominal aorta 
the kidneys were flushed with 0.01 M PBS. pH 7.4. for 
3-5 min until they blanched and were immediately thereafter 
perfused in situ with Fe 3 0 4 (BDH. Poole. UK), at a concen­
tration of 1.2 mg/lOOml PBS. The kidneys were removed, 
homogenized through a 90 μτη sieve and tissue particles were 
allowed to sediment for 20 min. The supernatant was 
removed, and the pellet resuspended in 50 ml PBS in a 
polypropylene tube which was then placed against 1 pole of 
a strong permanent magnet (magnetic inductance of 0.3 
Testa) [22]. Iron-loaded glomeruli were allowed to accumu­
late against the wall of the tube during 10 20 s, after which 
the supernatant with non-iron containing structures was 
removed. The glomeruli were resuspended in PBS. and the 
above described washing procedure was repeated three times. 
The final glomerular suspension was spread on 10 white 
0.8 μτη Sclcktron filters (Schlciger and Scrull, Dassel, 
Germany) with a diameter of 25 mm which were placed on 
a glass slide and covered with a coverglass. The dark 
glomeruli were counted twice microscopically, using an 
ocular grid. All filters contained 150-300 glomeruli with 
minimal (< 5%) contamination of non-glomerular structures, 
which were mostly tubuli or vascular fragments. 
Radioactivity of the counted glomeruli on 10 filters was 
measured in a gamma counter. Glomerular binding was 
expressed as pmol of bound antibody per kidney by using 
the equation: counts per minutes per glomerulus 
χ 12000/number of glomeruli χ specific activity (cpm/pmol ) 
[21]. The cpm/glomerulus were calculated, using the mean 
of the counts of the 10 glomerular suspensions. 
Albuminuria 
Albuminuria was measured in urine samples obtained by 
placing the animals in individual metabolic cages during 18 h 
[11] at the indicated day after i.v. injection of RaMGBM. 
The urinary albumin concentrations were measured by radial 
immunodiffusion using goat anti-mouse albumin antibodies 
[11.15]. 
Complement depletion 
Complement depletion was induced by daily i.p. injections 
of 30 U of CoVF (Cordis Laboratories, Miami, Florida. 
30 
USA) starting 1 day before induction of the nephnlis Serum 
hemolytic complement activity (CH50) »as assessed in a 
sensitive hemolytic assay as described previously [23] 
Leukon te depletion 
Mice were depleted of leukocytes by TBI as described 
previously [15 24] Irradiation was given in a single dose of 
7 5 Gy mm at a rate of 2 G> mm with a 13 MeV electron 
beam from a linear accelerator (COR Saturne Bue France) 
4 days before induction of the nephritis as maximal leukocyte 
depletion is reached at day 4 after TBI 112 24] Except for 
body weight loss for up to 20°/ after TBI no adverse 
reactions were observed in the animals They remained in 
excellent condition throughout the experimental period The 
effectiveness of TBI was monitored by leukocyte counting in 
a H*l automated cell counter (Bayer Technicon 
Tarrytown USA) 
Dtmetlnlsulfoxide treatment 
The role of reactive oxygen species was studied by admmis 
tering 100 μΙ of DMSO (Dimethylsulfoxide 100% Merck 
Darmstadt Germany) a scavenger of hydroxyl (OH ) rad 
icals ι ρ 30 mm before and concomitantly (ι ρ ) with the ι ν 
injection of RaMGBM Thereafter it was administered every 
12 h throughout the entire experimental period 
Histology and immunohiswlog\ 
After removal of the kidneys small fragments of renal cortex 
were fixed in Boum s solution dehydrated and embedded in 
paraplast (Amstelstad В V Amsterdam The Netherlands) 
Four μπι sections were stained with periodic acid Schiff 
( PAS land silver methenamine[l 1] ForIF kidney fragments 
were snap frozen in liquid nitrogen and 2 μπι cryostat 
sections were stained with FITC labeled swine anti rabbit 
Ig rabbit anti human fibrinogen that crossroads with mouse 
fibrinogen (DAKO Copenhagen Denmark) sheep anti 
mouse Ig heavy and light chains (Cappel Laboratories West 
Chester LSA) and goat anli mouse C3 (Nordic Tilburg 
The Netherlands) Glomerular PMN were counted in 4 pm 
sections stained with PAS The number of glomerular macro­
phages was determined in 5 μπι cryostat kidney sections 
using the rat anil mouse macrophage monoclonal antibody 
FA II [25 26] (kindly donated by Dr G L E Koch MRC 
Laboratory of Molecular Biology Cambridge UK ) as the 
first antibody in a 3 step avidin biotin technique with 
biotmylated goat anti rat IgG as secondary antibody 
(Vectaslain ABC Vector Laboratories Burhngame 
California USA) [27] The number of PMN and macro­
phages were counted in at least 40 glomeruli and expressed 
as the mean number per glomerular cross section The 
number of CD4 or CD8 positive lymphocytes in the glomeruli 
was assessed in an indirect IF technique using rat monoclonal 
antibodies directed against mouse CD4 and CD8 (clone 
GK1 5 and 2 43 respectively American Type Culture 
Collection Rockville MD USA Culture supernatants were 
received as a kind gift from Dr W van Ewijk Erasmus 
University Rotterdam The Netherlands) and FITC labeled 
rabbit anti rat lg (DAKO) as a second layer The staining 
intensity of glomerular depositions of rabbit Ig mouse Ig 
complement and fibrinogen was recorded semiquantitative^ 
on a scale from zero to 4 + as described before [II] For 
EM small pieces of the renal cortex were fixed in 2 5% 
glutaraldehyde dissolved in 0 1 M sodium cacodylate buffer 
pH 7 2 for 4 h at 4 С and washed several times in the same 
buffer The cortical fragments were postfixed in phosphate 
buffered Os0 4 for 2 h dehydrated and embedded in EPON 
812 Ultrathin sections were cut in an Ullrotome (LKB 
Bromma Sweden) and stained with У/ uranyl acetate for 
45 mm and with lead citrate for 2 min at room temperature 
The sections were examined in an electron microscope ( JEOL 
1200 fcX2 JbOL Tokyo Japan) 
Controls and statistical anali sis 
Since individual mice show a considerable variation in the 
albuminuric reaction to the administration of anti GBM 
antibodies no historical controls were used Each experiment 
was performed with age and sex matched controls For 
statistical analysis Wilcoxon s rank sum test was used Ρ 
values <0 05 were considered significant All values are 
expressed as means ±SD 
Results 
The heterologous phase ofanti GBM nephritis m beige 
mice and congenie conti ois 
All animals tolerated the induction of the nephritis 
well and underwent the placement in metabolic cages 
and the other experimental procedures without serious 
side effects Figure 1 shows the effect of injection of 
7 5 mg of RaMGBM (batch I) in groups of five beige 
mice and their congenie controls At 24 h after injection 
the non deficient control mice showed a massive albu 
minuria ( 12024+1680 μg 18 h) while the albumin 
excretion in the beige mice was 87 + 4 7 pg 18 h 
thus remaining within the physiologic range 
(49 + 1 9 p g l 8 h H = 30) consistent with our previous 
results [15] GBM binding of the RaMGBM as 
assessed with radiolabeled antibody was comparable 
in both strains (38 + 6 pmol glomerulus in C57BL 6J, 
+ / + mice and 43 ± 3 pmoles glomerulus in beige mut 
ants) From days 2 to 5 the albuminuria in the beige 
ALBUMINURIA (l10 9 μο/IBIWur·) 
1 8
 I *-C57Bjej, bg/bg • C97BI8J, +/+ 
β | 
:l 
г 
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Fig I Albuminuria after the ι ν injection of 7 5 mg RaMGBM Ig 
in C57BL 6J bg bg and C57BL 6J + + mice daily measured in 
separate groups of five mice per observation point 
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mice increased gradually from 2356+1365 at day 2. 
to 5700±1294 at day 3. 9542 + 3589 at day 4. and 
11 763± 1061 Mg 18 h at day 5 (Figure 1 ). By contrast, 
the early severe albuminuria on day 1 in the congenie 
controls did not further increase but remained at levels 
of 7904+1236 at day 2. 5359 ±2253 at day 3. 
8829 + 3448 at day 4. and 7698 ± 1262 με 18 h at day 5. 
Surprisingly, these striking differences in albuminuria 
in both strains were not reflected in the histology or 
immunofluorescence of the kidneys: at each observa­
tion point the morphologic changes were comparable 
in both strains. The glomerular influx of PMN in beige 
mice was not inhibited and. like in the congenie 
controls, was maximal at 2 h after the injection of the 
antibody ( Figure 2A). At 24. 48 and 72 h there was 
progressive endothelial swelling and cell necrosis 
accompanied by vascular thrombosis ( Figure 2B). At 
day 5 epithelial cell proliferation was observed occa­
sionally. By IF a strong, linear binding of rabbit Ig to 
the GBM was found in both beige and normal control 
mice throughout the observation period (Figure ЗА). 
From day 1. increasing deposition of fibrin was seen 
in the glomerular tufts in both strains (Figure 3B). 
Fine granular C3 deposits along the capillary wall, 
seen in both strains on day 1. had decreased at day 3 
(Figure 3C). consistent with our earlier findings [15]. 
No binding of mouse Ig to the GBM was observed in 
this phase. Only small amounts of mouse Ig and C3 
could be detected in mesangial areas in all mice (a 
normal finding in this species) and sparse granular 
deposits of mouse Ig were seen in areas of thrombosis. 
The number of glomerular macrophages on day 3. 
counted after immunostaining with FA 11 monoclonal 
antibody, was similar in beige and control mice (being 
1.2 + 0.2 and 1.1+0.2 cells glomerular cross section) 
and comparable to the values in untreated mice 
(1.1+0.2 and 0.8 + 0.3 cells glomerular cross section 
respectively in beige mice and C57 Bl 6J. + + con­
trols). The numbers of CD4 and CD8 positive cells in 
the glomeruli, as determined in at least 40 glomeruli 
of 5 mice per group at day 3. was comparable in 
treated and untreated beige mice (being 0.4 + 0.1 and 
0.3 ±0.1 cells glomerular cross section for CD4 positive 
Fig. 2. Microscopic findings in glomeruli of beige mice after ι ν 
present at 2 h: ( В) Al day 3. endothelial cell swelling (arrows), ι 
acid Schiff, χ 440). 
cells, and 0.2 ±0.1 and 0.2 + 0.1 cells glomerular cross 
section for CD8 positive cells respectively, and not 
different from those in congenie controls. 
Effect of leukocyte depletion 
Four days after TBI the leukocyte count was less than 
200 cells μ|. As previously shown. 20-25"» of these 
cells are PMN ( 12). These low levels were maintained 
during the whole experimental period (data not 
shown). At day 4 after TBI. RaMGBM was adminis­
tered i.v. Similar to our findings in normal mice. TBI 
prevented the albuminuria also in the beige mice. At 
3 days after injection the albuminuria did not exceed 
the physiologic level (Table 2). TBI by itself did not 
influence the albumin excretion. In IF a strong linear 
binding of rabbit Ig was observed along the GBM. but 
there was no C3 deposition in the capillary wall and 
no deposition of fibrin in the capillary tuft (Table 2). 
Light microscopy did not reveal glomerular damage in 
the TBI group. PMN were absent and macrophages 
were extremely scarce in the glomeruli at 2 h. while 
their numbers at day 3 were lower than in the non-
irradiated control animals (Table 1 ). 
F(ah')2 fragments 
I.v. administration of F(ab'), fragments of anti-GBM 
antibody did not cause albuminuria (Table 3). The 
glomerular binding of an equimolar dose and an equal 
protein dose respectively of radiolabeled F(ab'), frag­
ments was uninhibited, and even slightly higher than 
the binding of intact RaMGBM (P<0.01). as assessed 
with radiolabeled antibodies (Figure 5). Histological 
examination of the kidneys showed no abnormalities. 
IF showed a linear binding of the F(ab'), fragments 
to the GBM. and absence of C3 or fibrin deposits. The 
number of glomerular PMN at 2 h was identical to 
that in untreated controls, while no macrophages were 
seen at that time (Table 1 ). At day 3 PMN could not 
be detected in glomeruli, and glomerular macrophage 
counts were comparable to those in control mice 
(Table 1). 
linistration of RaMGBM. (A) Prominent influx of PMN (arrows) is 
ascular coagulation, and necrosis (arrowheads) can be seen (periodic 
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Fig. 3. Immunofluorescence of kidneys of beige mice at day 3 after induction of the nephritis. (A) Linear binding of rabbit anti-mouse 
GBM Ig to the glomerular capillary wall: (B) Segmental depositions of fibrin in the capillary tuft: (C) Deposits of C.Ì along the capillary 
wall and. in the mcsangium in non-CoVF treated mice: (D) Absence of C3 deposits in the capillary wall in CoVF treated mice ( χ 300). 
Table 1. Glomerular polymorphonuclear granulocyte ( PMN ) and macrophage ( MO) counts in kidney sections of C57BL 6J. bg bg ( beige) 
mice at 2 h and day 3 after injection of anti-GBM antibodies in different treatment protocols' 
Glomerular PMN b Glomerular M 0 C 
RaMGBM 
RaMGBM+CoVF 
RaMGBM 
RaMGBM+TB1 
RaMGBM Flab'h 
RaMGBM 
RaMGBM+ DMSO 
4.6± 1.3 (3)d 
5.9+1.3(3) 
6.0±0.5(3) 
0.0±0.0(3) 
0.6±0.5(3) 
9.1 ±1.9 (3) 
6.6+1.8(3) 
0.6±0.4(8) 
0.3 + 0.1 (3) 
0.2±0.1 (3) 
0.1 ±0.1 (7) 
0.0 + 0.0(5) 
0.3±0.2(6) 
0.2 + 0.1 (6) 
0.3 + 0.3(3) 
1.0 + 0.6(3) 
0.1 ±0.1 (3) 
0.0 + 0.0(3) 
0.1 ±0.1 (3) 
0.2±0.2(3) 
1.2 + 0.2(3) 
3.1 ±0.3 (5)' 
l.2±0.2(5) 
0.1+0.1 (5)' 
0.9±0.2(S) 
0.3+0.1 (3) 
0.2 + 0.1 (3) 
" RaMGBM. rabbit anti-mouse glomerular basement membrane antibody; CoVF. Cobra venom factor: TBI. total body irradiation: DMSO. 
dimelhylsulfoxide. 
b PMN were counted in at least 40 glomeruli in PAS stained kidney sections (mean ± SD). 
c
 M0 were immunohistologically stained with mAb FA 11 and counted in at least 40 glomeruli (mean + SD). 
d
 Number of mice between parentheses. 
e P < 0 . 0 l compared to untreated animals. 
f P<0.01 compared to non-irradiated controls. 
Complement depletion 
Consistent with our previous findings (13), daily i.p. 
administration of 30 U of CoVF resulted in unmeasur-
able CH50 titers throughout the experimental period 
(data not shown). The effects of complement depletion 
on albumin excretion and IF findings are summarized 
in Table 2. Complement depletion did not affect the 
level of albuminuria in beige mice. Non-CoVF treated 
control mice showed granular deposits of C3 in the 
capillary wall and in the mcsangium ( Figure 3C). In 
the CoVF treated group. C3 deposits could not be 
detected by IF, except for a faint diffuse staining in 
areas of glomerular necrosis (Figure 3D). The 
remaining morphologic and IF findings were similar 
to those described above for the non-CoVF treated 
groups (Table 2), with the exception of the number 
of glomerular macrophages, that proved to be 
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Table 2 Effect of total body irradiation Cobra Venom Factor or DMSO treatment on albuminuria and immunofluorescence findings in 
CS7BL 6J bg bt mice at day 3 after ι ν injection of anti GBM antibody 
No of 
animals 
Albuminuria 
Mg 18 hours 
Immunofluorescence* 
mlg 
RaMGBM+TBI* 
TBI 
RaMGBM 
RaMGBM + CoVP 
RaMGBM + O» NaCI 
RdMGBVl + DMSOr 
RaMGBM + 0 » NaCI 
16+10 
43 ±50 
5880 ±1387 
13476±4393 
10504 ±1680 
383 ±338" 
1I729± 10421 
+ + + +' 
+ + + +' 
+ + + +* 
+ + + +c 
+/++d 
+ + 
+ + 
'RaMGBM rabbit anti mouse GBM antibodies mlg mouse immunoglobulin 
bTBl total body irradiation (7 5 Gy) was given at day - 4 before injection of RaMGBM 
c
 Linear staining along the capillary wall 
dGrmular deposits in the capillary wall 
'CoVF Cobra Venom Factor was given in daily ι ρ injections of 30 U from day — I to + 3 after injection of RaMGBM 
r
 100 ug of DMSO (dtmethylsulfoxide) was given ι ρ before induction of the nephritis and every 12 h thereafter during 3 days 
h y < 0 01 compared to controls 
Table 3 Effect of ι \ administration of RaMGBM F(ab )2 fragments 
to C57BL 6J bg bg mice on albumin excretion on day 3 
F (ab ) dose Albuminuria (ug 18 h)" 
0 3 mg 
1 0 mg 
2 0 mg 
4 0 mg 
8 0 mg 
16 + 20 
35 ±33 
31 ± 13 
34±3I 
24±8 
*м=4 mean±SD 
DRIBS 
4 mg 
F(aD )1 
4 mg 
Fig 4 Quantitation of glomerular binding of , 2 , I labeled normal 
rabbit Ig intact R-lMGBM Ig and F(ab ). fragments of RaMGBM 
at I hatter iv injection in C57BL 6J bg bg */*<0 01 as compared 
with each previous observation 
significantly increased in the CoVF treated group 
(Table I) 
Dnnelln Imlfoxide treatment 
Treatment of mice with DMSO caused a considerable 
reduction in albuminuria at day 3, to levels of less 
than 5% of those of non-DMSO treated controls It 
also reduced the glomerular damage at day 3, ι e the 
deposition of fibrin and the necrosis in the capillary 
tufts, as assessed by light microscopy and IF (Table 2) 
At 2 h after injection of RaMGBM the kidneys of 
DMSO treated mice showed a moderately reduced 
influx of PMN, and glomerular macrophage counts in 
DMSO treated and non DMSO treated mice were 
identical (Table I) EM examination at 2 h showed 
glomerular damage both in DMSO treated mice and 
controls ι e PMN that attached to the GBM between 
the moderately swollen endothelial cells At day 3 the 
glomeruli of control mice showed severe endothelial 
cell damage, with swelling lysis and detachment from 
the GBM while at many sites cellular debris and fibrin 
fibrils could be observed between the damaged endo­
thelial cells and the GBM In the DMSO treated mite 
the glomerular damage was less prominent with only 
moderate endothelial cell damage (not shown) 
Discussion 
Our results show that, m spite of preventing the 
albuminuria at day 1 after injection of RaMGBM the 
leukocytic neutral proteinase deficiency of the beige 
mutant does not inhibit or delay the development of 
glomerular lesions, and from day 2 albuminuria 
develops rising to levels comparable to those of con-
genie nephritic controls from day 3, ι e clearly within 
the time limits of the heterologous phase Both this 
late albuminuria and the glomerular lesions can be 
prevented by depletion of PMN and removal of Fc 
fragments in the RaMGBM, and can be considerably 
reduced by ROM scavenging As shown by the binding 
studies with radiolabeled antibodies, the absence of a 
nephritic effect of the F(ab ) 2 fragments could not be 
attributed to loss of binding to the GBM The glomer­
ular accumulation of PMN, from 30 mm after injection 
of antibody to a maximum at 2 h, was similar in beige 
mice and congenie controls These findings indicate 
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that the heterologous phase in murine anti-GBM neph­
ritis can be divided in at least two subphases with 
different Fc-mediated pathogenic pathways a first 
albuminuric episode predominantly mediated by the 
action ol' leukocytic neutral proteinases, and a second 
phase with glomerular damage and albuminuria that 
are dependent on other Fc-mediated effector systems, 
such as the production of ROM 
Our data strongly point to PMN as the essential 
mediators not only for the first, but also for the second 
phase Apart from PMN, other cells bearing one of 
the three known receptors for the Fc part of Ig are 
monocytes/macrophages, natural killer cells (NK ). and 
platelets The characteristics of the Fc receptor have 
been extensively studied in human leukocytes, but data 
on the murine system are incomplete (28) It is gener­
ally assumed that there are many analogies between 
the systems in man and mice, with the exception that 
on mouse platelets no Fc receptors have been demon­
strated [29-31 ] With regard lo a possible involvement 
of macrophages, in our experimental groups only the 
CoVF treated beige mice showed an increase of FA/l 1 
positive cells in the glomeruli ( Table 1 ) This somewhat 
unexpected finding will require further study In all 
other groups the number of macrophages, counted at 
day 3 after RaMGBM injection, did not differ from 
the number seen in normal beige controls Consistent 
with these findings, Holdsworth el al found no increase 
of glomerular macrophages during the heterologous 
phase of anti-GBM nephritis in rats and rabbits [32] 
In these species they demonstrated that macrophages 
only start to accumulate in the glomerular tuft when 
the animal produces antibodies to the heterologous Ig, 
indicating that macrophages do not mediate damage 
prior to the onset of the autologous phase Holdsworth 
et al attributed the sequential glomerular accumulation 
of PMN and macrophages to different affinities of 
these cells for the Fc part of the heterologous and 
autologous antibodies respectively [33] We have tried 
to induce a highly selective depletion of PMN without 
an effect on monocytes by treatment with a rat mono­
clonal anti-mouse PMN antibody (NIMP-R14), kindly 
provided by M Strath (National Institute for Medical 
Research, Mill Hill, London, UK) [34] In a pilot 
experiment we found indeed a severe depletion of 
PMN accompanied with inhibition of the albuminuria 
(data not shown) However, like the TBI, the treatment 
with NIMP-R14 did not only induce PMN depletion, 
but also reduced the levels of monocytes by more than 
90%, thus giving no essential additional information 
about a potential influence of monocytes 
With regard to lymphocytes, a possible role for these 
cells in the development οΓ anti-GBM nephritis has 
only been postulated in a WKY rat model [35-37], in 
which increase of CD8 positive cells preceded a glomer­
ular increase of macrophages and induction of glomer­
ular lesions Depletion of CD8 positive cells by 
injection of monoclonal antibodies abolished the glom­
erular macrophage invasion and also the glomerular 
lesions [37] The authors suggest that the CD8 positive 
cells may be NK cells, that are involved in ADCC 
activity, and influence the increase of macrophages 
with resulting immune injury by factors released after 
binding of their Fc receptor to the GBM fixed antibod­
ies In our model it is very unlikely that CD4 or CD8 
positive lymphocytes are involved in the induction of 
glomerular damage in the heterologous phase, since 
we did not find any differences in CD4 and CD8 
positive cell counts between nephritic beige mice and 
normal controls Moreover, the role of CD8 positive 
lymphocytes in the WKY rat model concerns pro­
teinuria that appears at day 7, a time at which the 
autologous phase has already started A possible role 
for NK cells is also unlikely in our model, since beige 
mice are known to have decreased numbers of circulat­
ing NK cells [38] 
Although a role for platelets and the coagulation 
system has been demonstrated in several models of 
experimental nephritis [30], such an effect could not 
be demonstrated in our model, since platelet aggrega­
tion and fibrin deposition were not seen before PMN 
accumulation and endothelial cell swelling were already 
evident The coagulation is probably initiated by the 
endothelial cell damage with concomitant upregulation 
of procoagulant activity, or by mediators, released by 
the PMN after their adherence to the endothelial cell 
Preliminary data show that platelet depletion has no 
influence on the albuminuria (manuscript in 
preparation) 
When concentrating on PMN as the most likely 
inducers of the glomerular lesions in the heterologous 
phase of murine anti-GBM nephritis, the more specific 
effector mechanism that inflicts the damage to the 
endothelial cells and the albuminuria in the late hetero­
logous phase remains to be defined further brom the 
results in the beige mice elastase and cathepsin G can 
be excluded as essential mediators in the late albumin­
uria of days 2-5, leaving other systems such as ROM. 
acid-, basic-, or metalloproteinases as effector systems, 
either apart or in cooperation PMN are the principal 
source of ROM in inflammation [39.40]. and in our 
model of glomerulonephritis PMN accumulate in the 
glomerular tuft soon after the ι ν administration of 
RaMGBM [11] In beige mice this influx of PMN also 
occurs, and ultraslructurally there is evidence of endo­
thelial cell damage in both strains from 2 h after the 
i v injection of the anti-GBM antibodies [15] PMN 
from beige mice can produce ROM in amounts equal 
to those of congenie controls when properly stimulated 
[15] Fc receptor mediated stimuli have been shown to 
trigger an oxidative burst from leukocytes with the 
generation of ROM that may play a role in the cellular 
injury and albuminuria which accompany PMN-
dependent glomerulonephritis [31.39-41] The gener­
ated ROM can also inhibit ADP-ase activity and ADP-
ase mediated anti-thrombotic activity, as was recently 
shown in a passive anti-GBM nephritis in the rat [42] 
The glomerular endothelial cells, damaged by leuko­
cytic ROM, may in turn generate potent proinflam­
matory agents [43], causing activation of coagulation 
system, platelets [31], and complement system The 
finding that DMSO treatment, with only moderate 
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reduction of PMN accumulation, almost completely 
suppressed the late albuminuria, also suggests a role 
for ROM, or. more specificali}, hydroxyl radicals in 
the pathogenesis of the albuminuria and morphological 
damage in the late heterologous phase In passive anti-
GBM nephritis in rats and rabbits the mediation of 
glomerular injury by ROM was demonstrated by 
Renan et al [44] and Boyce el al [45], and ROM 
have been identified as mediators m the pathogenesis 
of other models of glomerulonephritis [reviewed in 41 ]. 
In earlier experiments we could not demonstrate a 
protective effect of ROM scavengers for the early 
albuminuria of the first day in normal C57B1/6J mice 
[15] We therefore assume that ROM as such have no 
direct effect on the permeability of the glomerular 
filler One could speculate that ROM, generated by 
PMN, act by stimulating or damaging endothelial cells 
or other resident glomerular cells, that in turn release 
mediators that are responsible for the albuminuria and 
the intravascular coagulation seen in the late heterolog­
ous phase This hypothesis is, however, not supported 
by our finding that scavenging of hydroxyl radicals 
did only partly reduce the endothelial changes that are 
already visible from 2 h after injection of RaMGBM 
At this moment it is not clear whether ROM can 
induce albuminuria by a direct, but slowly developing 
injury to the OBM, or by triggering of other medi­
ator systems 
In conclusion, our studies in normal C57B16J mice 
and the beige mutants show that in the heterologous 
phase of murine anti-GBM nephritis a short initial 
subphase can be recognized, characterized by an early 
severe albuminuria that is dependent on the presence 
of leukocytic neutral proteinases The glomerular 
lesions and the more gradually developing albuminuria 
of the later days depend on other, most likely also 
PMN dependent effector systems One of the mediator 
systems that play a role in this neutral proteinase 
independent damage is that of ROM, derived from the 
activated PMN, and most likely acting indirectly by 
damaging endothelial cells or other resident glomerular 
cells further studies are necessary to confirm this 
hypothesis and to delineate the possible involvement 
of other mediator systems, including those effected by 
resident glomerular cells that may play a role m the 
late heterologous phase 
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Chapter 4 
The late heterologous phase of anti-GBM nephritis. Inability to 
prevent albuminuria by platelet depletion or defibrinogenation in 
beige mice 
G.W. Feith, K.J.M. Assmann, M.J.J.T. Bogman, A.P.M. van Gompel, J. Schalkwijk, 
and R.A.P. Koene 
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Summary 
Intravenous injection of rabbit anti-mouse glomerular basement membrane antibody 
(RaMGBM) in C57B1/6J mice induces a severe, complement-independent 
albuminuria within 24 h. During these first 24 hr the albuminuria appears to depend 
on the effect of neutral proteinases released from polymorphonuclear granulocytes 
(PMN), since in the congenie mutant beige strain (C57B1/6J, bg/bg), which is 
deficient for these enzymes the albuminuria starts only at day 2 and reaches control 
levels by day 3. Endothelial damage, platelet aggregation and deposition of fibrin are 
similar in both strains. We therefore tested the role of platelets and fibrin in this later 
phase by treating C57B1/6J, bg'bg mice with rabbit anti-mouse platelet antibodies 
(RaMP) and defibrinogenation with ancrod. Treatment with RaMP reduced 
circulating platelets to levels below 20 χ 109/1, and by electron microscopy no 
platelets were found in the glomeruli at any time. Treatment with ancrod lowered 
serum fibrinogen to immeasurable levels. Neither treatment with RaMP nor with 
ancrod reduced the albuminuria or the endothelial damage at day 3 after RaMGBM. 
Glomerular PMN accumulation was not affected by RaMP, and only slightly reduced 
by ancrod. We conclude that platelets are not essential mediators of albuminuria or 
glomerular damage in the later heterologous phase of anti-GBM nephritis in beige 
mice. The contribution of fibrin to the glomerular damage, at least in its non-
polymerized form, could not be firmly established, since ancrod treatment, despite 
effective defibrinogenation, did not inhibit glomerular fibrin deposition. 
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Introduction 
In the model of mouse anti-glomerular basement membrane (GBM) nephritis, that is 
induced by i.v. injection of rabbit anti-mouse GBM antibody (RaMGBM) in 
C57B1/6J mice [1] , we have recently shown that the heterologous phase of the 
induced nephritis is biphasic [2]. The severe albuminuria that develops within the 
first 24 h after injection of RaMGBM is dependent on the effect of neutral 
proteinases released from polymorphonuclear granulocytes (PMN) accumulated in 
the glomeruli [3,4]. In the beige mutant of the C57B1/6J strain (C57B1/6J, bg/bg), 
that is deficient of leukocytic proteinase activity, the early proteinuria of the first day 
is completely absent [4]. In this strain we found that from day 2 on a gradually 
increasing albuminuria developed, which by day 3 after injection of RaMGBM had 
reached levels similar to those in the normal C57B1/6J controls. It was accompanied 
by similar degrees of endothelial cell damage and intravascular coagulation [2]. This 
shows that, in contrast with the initial phase, the second part of the heterologous 
phase of the anti-GBM nephritis is not dependent on leukocytic proteinase activity. 
Since neither the first nor the second phase of the heterologous anti-GBM nephritis is 
dependent on complement activation or monocyte/macrophage function [2], and 
since intravascular coagulation is a prominent morphological feature in this phase, 
we tested the role of platelet and the coagulation system in the induction of the 
glomerular damage from day 2-5 after injection of RaMGBM. To exclude a possible 
delayed effect of leukocytic proteinases, released from PMN in the period of 
accumulation during the first hours after RaMGBM injection, we performed the 
experiments in the beige mutant of the C57B1/6J strain [3,4]. 
Methods 
Animals 
C57B1/6J mice and the beige mutants (C57B1/6J, bgbg) were bought from the 
Jackson Laboratory (Bar Harbor, Maine, USA). New Zealand White rabbits, used for 
the preparation of the anti-mouse GBM (RaMGBM) and anti-mouse platelet (RaMP) 
antibodies, and as a source of normal rabbit immunoglobulin (Ralg), were bought 
from a local breeder. 
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Anti-mouse GBM nephritis 
Anti-GBM antibodies were prepared in rabbits as described before [1,3]. The Ig 
concentration of the final preparation as determined by radial immunodiffusion [5] 
was 15 mg/ml. 
Platelet depletion 
Platelets for preparation of RaMP were purified from whole blood from C57B1/6J 
mice drawn from the retrobulbar plexus and collected in siliconized tubes containing 
3.8% trisodium citrate (NPBI, Emmer Compascuum, The Netherlands) (9:1 vol/vol). 
After cenrrifugation at 150 g for 10 min and removal of the pellet, the platelet rich 
plasma fraction was centrifuged at 1000 g. After discarding the supernatant, the 
platelet pellet was resuspended in cold saline, and platelets were counted in a H*l 
automated cell counter (Bayer-Technicon, Tarrytown, USA). Rabbits were 
immunized by s.c. injection of 3xl08 platelets, emulsified in CFA (Difco 
Laboratories, Detroit, Michigan, USA), followed by three boosters of an equal dose, 
emulsified in IFA (Difco), and given at four week intervals. After bleeding, pooled 
sera of five rabbits were decomplemented by heating for one h at 56CC, and 
subsequently absorbed once with buffycoat rich rat erythrocytes (1:1 vol/vol) and 
twice with buffycoat rich mouse erythrocytes (4:1 vol/vol). The Ig fraction of the 
sera was purified by Protein A column chromatography (Pharmacia, Uppsala, 
Sweden), and, after dialysis against PBS, concentrated with a Amicon XM 50 filter 
(Amicon, Danvers, Massachusetts, USA) to a final Ig concentration of 8 mg/ml, as 
determined by the Lowry assay [6]. The efficacy of the antibody was tested in 
otherwise untreated beige mice, in which a single injection of 2 mg of the RaMP 
preparation induced a severe thrombocytopenia, with platelet counts lower than 
20x109/l within 6 h and persisting for 24 h. In the experimental groups, in which i.p. 
administration of RaMP was followed by the i.v. administration of RaMGBM, the 
induced thrombocytopenia did not persist for 24 h as in normal beige mice. 
Therefore, in these mice RaMP was given every 12 h during the first two days, and 
every 6-8 h during the third day, in order to maintain platelet counts lower than 20x 
109/1 throughout the experimental period. Normal Ralg, used for control groups, was 
prepared from sera of untreated rabbits and purified as described for RaMP. Absence 
of reactivity of RaMP and Ralg with mouse erythrocytes was verified in a 
hemagglutination assay and by assessment of haemoglobin and haematocrit levels in 
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mice 24 h after administration of RaMP or Ralg. A possible reactivity with 
leukocytes was excluded by assessing the total leukocyte and differential count in 
blood samples taken from mice 24 h after RaMP or Ralg administration, in an H* 1 
automated cell counter with software adaptions for small laboratory animals. 
Defibrinogenation 
Defibrinogenation was effected by repeated s.c. injections of ancrod (Arwin, Knoll 
GmbH, Ludwigshafen, Germany), the anti-coagulant fraction of the venom of the 
Malayan pit viper (Aghstrodon rhodostoma) [7,8]. The efficacy of defibrinogenation 
was assessed in a sensitive fibrinogen assay as described by Clauss [9]. The blood 
samples were anticoagulated with 3.8% trisodium citrate (9:1 vol/vol), centrifuged 
for 15 min at 4000 g, at 4 °C after which the plasma was collected. After two min 
preincubation of 200μ1 plasma at 37 °C (0,9% NaCl added to reach the desired 
dilution), ΙΟΟμΙ thrombin (100 NIH units/ml Owren's buffer) was added and the 
clotting time recorded. The fibrinogen concentration was calculated from a double 
logarithmic standard curve representing the relationship between clotting time and 
mouse fibrinogen concentration. The lower detection limit of the assay was 120 mg/1. 
Fibrinogen levels in saline treated controls were 2131 ± 601 mg/1 (n = 8). 
Histology 
For light microscopy (LM) kidney fragments were fixed in Bouin's solution, and, 
after dehydration and embedding in paraplast, (Amstelstad B.V., Amsterdam, The 
Netherlands) 2 μτη sections were stained with periodic acid Schiff and silver 
methenamine [1]. For immunofluorescence (IF) kidney fragments were snap frozen 
in liquid nitrogen, and 2 цт cryostat sections were stained with FITC-labeled swine 
anti-rabbit Ig (DAKO, Copenhagen, Denmark), sheep anti-mouse Ig (Cappel 
Laboratories, West Chester, USA), goat anti-mouse C3, and rabbit anti-mouse 
fibrinogen (both from Nordic, Tilburg, The Netherlands). The sections were 
examined in a Leitz fluorescence microscope, and the staining intensity of the 
glomeruli was recorded semiquantitatively on a scale from zero to 4+ as described 
earlier [1]. For electron microscopy (EM) kidney fragments were fixed in 2.5% 
glutaraldehyde, and processed as described before [4]. 
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Experimental protocol 
A. Platelet depletion to levels below 20х109Л was induced and maintained 
throughout the entire experimental period of three days by repeated i.p. injections of 
RaMP. To avoid bleeding complications in the experimental groups we tested the 
effect of the RaMP on platelets, haematocrit, serum albumin concentration, and 
leukocyte numbers in separate parallel groups of normal and nephritic mice, with 
intervals of 8 h. In platelet depleted mice 0.3 ml syringes with 29 G needles (Becton 
Dickinson, Franklin Lakes, New Jersey, USA) were used for all i.v. and i.p. 
injections to reduce haemorrhagic complications, and haemostasis at the injection 
site was promoted by use of Clinospon (E.N. Furrer Healthcare, Dälikon, 
Switzerland) and Nobecutane aerosol spray dressing (Astra, Rijswijk, the 
Netherlands). 
In the nephritic groups the first RaMP injection, in a dose of 2 mg, was given 6 h 
before the i.v. injection of RaMGBM. A second dose (0.8 mg) was given 
simultaneously with the RaMGBM (1 mg). In the following days RaMP (2 mg) was 
injected i.p. at 12, 24, and 36 h after RaMGBM, followed by lower doses (1.5 mg) 
at 44, 52, and 66 h, to maintain the desired level of thrombocytopenia. Instead of 
RaMP, control mice received equivalent doses (2 mg, 0.8 mg and 1,5 mg 
respectively) of normal Ralg. From 54 h (day 3), the mice were placed in individual 
metabolic cages to collect 18 h urine samples for determination of albuminuria [1,4], 
and after this bled for assessment of haematological parameters and for histological 
examination of the kidneys. To exclude a possible effect of RaMP treatment on 
glomerular PMN accumulation three mice of each group were sacrificed at 2 h after 
injection of the RaMGBM and the kidneys were processed for LM and EM. 
Glomerular PMN accumulation was determined by counting PMN in at least 40 
glomeruli per mouse, and given as mean values per glomerular cross section. 
B. Defibrinogenation was induced and maintained by s.c. injections of 1.5 U of 
ancrod (0.1 ml) at 8 h intervals from 48 h before the i.v. injection of 1 mg of 
RaMGBM, using 29G needles as mentioned above. Control mice received similar 
volumes of 0,9% NaCl. Glomerular PMN accumulation at 2 h after injection of 
RaMGBM was determined in three mice per group as described above. Throughout 
the experimental period every 24 h three mice were bled for control assessment of 
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fibrinogen levels. From 54 h (day 3), 18 h urine samples were collected for 
measurement of the albuminuria, after which the mice were sacrificed for 
histological examination of the kidneys, as described above. 
Statistics 
For statistical analysis, Wilcoxon's rank sum test was used. Ρ values <0.05 were 
considered significant. All values are expressed as means ± SD. 
Results 
Effect of platelet depletion 
The repeated injections of RaMP were well tolerated by the mice apart from 
incidental fatal haemorrhages. Platelet levels remained < 20 χ 109/1 throughout the 
experimental period. At day 3 after injection of RaMGBM haematocrit and leukocyte 
counts were only moderately decreased compared with the values in Ralg treated 
control mice, with significant differences only for the haematocrit values (Table 1). 
Glomerular PMN accumulation at 2 h after injection of RaMGBM was not affected 
by RaMP treatment, being 4.1 ± 0.4 PMN per glomerular cross section in RaMP 
treated mice vs 5.2 ± 1.2 in Ralg treated controls. In EM, both groups showed similar 
adherence of PMN to the GBM, with comparable swelling of endothelial cells at 2 h. 
As shown in Table 2, the albuminuria at day 3 was not affected by RaMP treatment 
when compared to that in Ralg treated mice. The glomeruli of RaMP treated mice 
and Ralg treated controls showed, at day 3, comparable swelling and necrosis of 
endothelial cells, and focal deposition of fibrin (Fig. 1). In IF glomerular deposition 
of RaMGBM, C3, and fibrin were also similar in both groups (Table 2). Apart from 
the expected strong linear binding of the injected RaMGBM to the GBM, a few 
granular deposits of C3 were seen, with deposition of fibrin in one or more capillary 
loops of about 50% of the glomeruli (Fig.2). Mouse Ig was only present in small 
amounts in the mesangium and was scored as negative, since this is also found in 
normal mice. By EM, only the Ralg controls showed an occasional presence of 
platelets in the capillary lumina, while in the RaMP treated mice no platelets were 
seen at any time. Otherwise the changes were comparable: the endothelial cells were 
swollen, partly detached from the GBM, and surrounded by deposits of granular or 
fibrillar (fibrin) material (Fig.3A). 
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Table 1. Haematological effects of treatment with rabbit anti-platelet serum (RaMP) 
in C57B1/6J, bg bg mice, measured at day 3 after induction of the nephritis by rabbit 
anti-mouse GBM antibody (RaMGBM). 
Treatment Platelets 
χ10'9Λ 
17 ± 5 ° 
395 ± 227 
Haematocrit 
a/i) 
0.24 ± 0,08 * 
0.34 ± 0,06 
Leukocytes 
x№
9/\ 
3.7 ± 1,1 c 
6.1 ±2.6 
RaMP 
Ralg : 11 
1) RaMP was injected i.p. at 6 hr (2mg) before and simultaneously (0.8mg) with 
RaMGBM, followed by repeated doses at 12, 24, 36 h (2mg), and 44, 52, 66 h 
(1.5mg) after induction of the nephritis. 
2) Control mice received normal rabbit Ig in similar doses and at similar intervals 
before and after RaMGBM. 
" P<0.002 compared to Ralg treated controls 
* P<0.01 compared to Ralg treated controls 
c
 NS compared to Ralg treated controls 
Figure 1 Glomerulus of RaMP 
treated C57B1/6J, bg bg mouse at 
day 3 after injection of 
RaMGBM There is swelling and 
necrosis of glomerular endothelial 
cells (arrow) (methenamine silver 
staining, x510) 
47 
Table 2. Effect of rabbit anti-mouse platelet Ig (RaMP) and ancrod treatment on albuminuria 
and immunofluorescence findings in glomeruli of C57BL/6J, bg bg mice at day 3 after i ν 
injection of anti-GBM antibody 
Treatment Albuminuria Immunofluorescence 
(Mg/18hr) RaMGBM ' C3 fibrin m Ig* 
RaMP' + RaMGBM 
Ralg' + RaMGBM 
8 10,301±6067 ++++' +« ++ 
11 7835±6320 ++++' +« ++ 
ancrod + RaMGBM 
0,9%NaCl + RaMGBM 
12,256±9697 ++++* +« ++ 
7443±5365 ++++ + ' ++ 
" RaMGBM rabbit anti-mouse GBM antibody was injected i ν at 0 hr 
* mlg deposition of mouse immunoglobulin in the capillary wall 
c
 RaMP rabbit anti-mouse platelet Ig was injected i ρ at -6 hr and simultaneously with 
RaMGBM, followed by repeated injections every 12 hr (days 1 and 2) and every 6-8 hr (day 
3) respectively 
* linear staining along the capillary wall 
' granular deposits in the capillary wall 
1
 Ralg normal rabbit immunoglobulin, injected in similar doses as RaMP 
Effect of defibrmogenation with ancrod 
The repeated injections of the mice with ancrod were tolerated without apparent side 
effects, and induced an effective defibrogenation with unmeasurable fibrinogen 
levels throughout the entire experimental period, i.e. less than the lowest level of 
detection of 120 mg/1. Defibrmogenation with ancrod did not affect haematocrit, 
leukocyte numbers, or serum albumin concentration (data not shown). However, 
administration of ancrod reduced the glomerular accumulation of PMN at 2 h after 
the induction of the nephritis by about 40%, being 4.9 ± 1.2 vs. 8.4 ± 2.2 PMN per 
glomerular cross section in ancrod and saline treated mice respectively. As shown in 
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Figure 2. Immunofluorescence findings in glomerulus of RaMP treated C57B1/6J, bg bg mouse at day 
3. A, Linear binding of injected anti-GBM antibodies B, Few granular deposits of C3 in capillar) 
loops and mesangium C, Prominent fibnn deposits in glomerular vessels (arrows) (A,B, and C. x510) 
49 
-^ «£ -* A-'\~, ...'-
Figure 3. Electron microscopy of glomerulus of RaMP treated mouse at day 3 after administration of 
RaMGBM. A, Extensive endothelial cell damage (arrows) and deposition of granular material 
(asterisk) after treatment with ancrod (xl3,500). B, Sheaves of polymerized fibrin in capillary lumen of 
control mouse, injected with saline instead of ancrod (arrows) (x20,600). 
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Table 2, treatment with ancrod did not inhibit the albuminuria at day 3 after 
RaMGBM. By LM the morphological damage at day 3 after injection of RaMGBM 
was similar in ancrod and saline treated mice and comparable to the morphological 
lesions described above for the platelet depleted mice. Immunofluorescence findings 
were also not different in the examined groups. Surprisingly, the IF staining 
intensities of the fibrin deposits were similar in the ancrod treated mice and the 
saline treated controls. By EM we found the typical, polymerized fibrin fibrils in the 
glomerular capillaries of control mice. However, the glomeruli of ancrod treated 
mice showed abundant deposits of granular material only (Fig ЗА and B). When we 
tested whether the deposition of these presumably non-polymerized fibrin or 
fragments thereof could be prevented by higher doses of ancrod, we found that even 
seven fold higher doses could not prevent this phenomenon. 
Discussion 
It is clear from our earlier studies that for the development of anti-GBM nephritis in 
the mouse PMN are essential mediators. The early albuminuria in the first 24 h is 
effected by the neutral proteinases [3,4]. For the albuminuria of day 3-5 and for the 
development of the glomerular lesions, however, leukocytic proteinases are not an 
essential requirement. In this later stage PMN must act via a different pathway, either 
directly by cellular components other than the neutral proteinases, or indirectly by 
activation of other systems in the amplification cascade of the inflammatory reaction. 
The appearance of prominent intravascular coagulation simultaneously with the 
endothelial cell changes prompted us to test whether the PMN had a role as 
activators of the coagulation system, with consequent tissue damage by release of 
platelet derived mediators or by events following deposition of fibrin. Our results 
show that, in the presence of unaltered PMN influx, neither platelet depletion nor 
defibrinogenation prevented the albuminuria or the glomerular lesions. 
The role of platelets in the heterologous anti-GBM nephritis has been studied in a 
restricted number of species [10,11]. In rats, platelet depletion reduced the 
glomerular injury in the heterologous phase [10], whereas in mice no effect of 
platelet depletion has been found [11]. In the rat study of Wu et al. [10] the effect of 
platelet depletion may have been secondary to an effect on PMN, since treatment 
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with anti-platelet antibody diminished the glomerular influx of PMN by 50% and 
reduced the proteinuria in the early heterologous phase by 75%. Studies on the role 
of platelets in the autologous phase of anti-GBM nephritis in rabbits have provided 
controversial findings [12,13]. In three other autologous models of 
glomerulonephritis a role of platelets, with or without the involvement of PMN, has 
been demonstrated. This regards the con Α-anti conA model [14], the anti Thy-1 
model [15] and the mesangial proliferative glomerulonephritis induced by Habu 
snake venom in the rat [16]. By contrast, no role for platelets could be demonstrated 
in acute serum sickness in rabbits [17]. 
Theoretically, platelets can induce glomerular damage in several ways, the most 
important being the release of inflammatory mediators in the process of aggregation 
and induction of coagulation, including vasoactive substances and arachidonic acid 
metabolites. The vasoactive compounds can alter glomerular hemodynamics leading 
to an enhanced glomerular permeability [18,19]. Moreover, positively charged 
proteins and GBM degrading enzymes from activated platelets can perturb the charge 
and size barriers of the GBM [18,19]. Platelets also release growth factors that 
induce cell proliferation. 
Defibrinogenation with ancrod is an accepted experimental method to prevent 
formation of polymerized fibrin, and thus to examine the role of fibrin deposition in 
the evolution of inflammatory tissue damage [7,20]. Ancrod, by its venom derived 
proteolytic enzyme, causes enzymatic cleavage of fibrinopeptide A from fibrinogen, 
with consequent blocking of normal polymerization of fibrin fibrils during the 
formation of blood clots [7,20]. It also increases degradation of the non-polymerized 
fibrin by activation of the fibrinolytic system [21]. Thusfar all studies investigating 
the role of fibrin in experimental glomerulonephritis have used ancrod to achieve 
effective defibrinogenation. Apart from our current study, there is only one other 
investigation reporting on the effect of fibrin in the heterologous phase of anti-GBM 
nephritis: Wu et al. [22] found that, in rats, ancrod treatment decreased the 
proteinuria in the heterologous phase by 70%. Their study suggests that fibrinogen 
mediates platelet-PMN cooperation. Two other models regard the autologous phase 
of anti-GBM nephritis and the chronic immune complex glomerulonephritis in 
rabbits [8, 23-25]. Defibrinogenation in these two models had only an inhibitory 
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effect on crescent formation, but did not alter the proteinuria. These latter results are 
in accordance with our finding that ancrod treatment had no effect on albuminuria. 
Our finding that ancrod treatment, even in very high doses, had no effect on fibrin 
deposition was unexpected. In other species ancrod not only induces severe 
hypofibrinogenemia but also considerably decreases fibrin accumulation in the 
glomeruli [22-26]. In EM we saw the characteristic sheaves of polymerized fibrin 
only in the non-ancrod treated mice. In ancrod-treated animals we found only 
granular material that, given the positive staining for fibrin in IF, must contain a 
considerable amount of non-polymerized fibrin products. This suggests that in this 
mouse model ancrod effectively prevented the polymerization of fibrin monomers. 
An alternative explanation for the persistence of the fibrin deposits may be that in 
mice (and possibly also in rats), ancrod treatment does not affect the fibrinogen 
reservoirs of the α granules that are released after activation of platelets [27]. From 
our results with ancrod treatment we may conclude that fibrin in its polymerized 
form does not participate in the induction of the albuminuria and glomerular damage, 
but we cannot rule out an involvement of fibrin monomers or their breakdown 
products. 
In recent studies we found that blocking of reactive oxygen metabolites by 
dimethylsulphoxide (DMSO) treatment can considerably reduce both the glomerular 
damage and albuminuria. This suggests that at least part of the effect of the PMN is 
mediated by oxygen radicals [2]. Further studies should therefore concentrate on 
other possible effector mechanisms of PMN, and also on the role of the resident 
glomerular cells in the mediation of the inflammatory reaction. 
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Abstract 
Background: Intravenous administration of clodronate (dichloromethylene 
bisphosphonate) containing liposomes (clodro-L) has been reported to induce 
selective depletion of tissue macrophages (Μφ) with little or no effect on 
polymorphonuclear granulocytes (PMN). 
Therefore we used clodro-L to study the role of Μφ in a PMN-dependent model of 
anti-glomerular basement membrane (GBM) nephritis. 
Methods: C57BL/6J mice received clodro-L i.v. at day -2 and -1 before i.v. injection 
of anti-GBM antibodies. The albuminuria of the first 24 hours was measured by 
radial immunodiffusion in 18 hr samples and glomerular changes were studied 
histologically and immunohistologically. 
Results: Treatment with clodro-L, in doses that adequately destroyed the Kupffer 
cells, failed to reduce glomerular Μφ numbers, but markedly inhibited glomerular 
PMN accumulation. Compared to control mice, clodro-L pretreated C57BL/6J mice 
showed considerable reduction of both albuminuria and glomerular damage at day 1 
after injection of rabbit anti-GBM antibody. 
Conclusions: In this PMN dependent model, the inhibitory effect of clodro-L 
treatment on the development of nephritis is very likely due to the inhibition of 
glomerular PMN accumulation. Our results indicate that clodro-L treatment as a 
method of selective Μφ depletion, has its limitations, especially in models in which 
PMN are involved as effector cells. 
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Introduction 
In vivo studies of cellular mediators in experimental models of disease usually 
include selective depletion of the inflammatory cells under investigation. The method 
of choice to induce such depletion depends on the cell type, the animal species used, 
the kinetics of repopulation in combination with the duration of the experiment, and 
the severity or the methodological consequences of unwanted side effects. For 
depletion of cells of monocyte/macrophage (Μο/Μφ) origin several procedures have 
been proposed, which mostly are based on the phagocytic potential of these cells [1-
3]. A successful and widely used method is injection of clodronate 
(dichloromethylene bisphosphonate), encapsulated in liposomes (clodro-L), which 
has been reported to induce selective and long term elimination of Мф, without 
deleterious effects on granulocytes or lymphocytes [2, 5-8]. 
In our experimental model of mouse anti-glomerular basement membrane (GBM) 
nephritis the nephritic reaction is induced by i.v. injection of rabbit anti-mouse GBM 
antibody in C57BL mice [9]. This results in early glomerular accumulation of PMN, 
albuminuria, and glomerular damage. Depletion of PMN by total body irradiation 
completely prevented the early nephritic reaction [10]. Further evidence for a critical 
role of PMN was obtained by injection of anti-GBM antibody in a mutant mouse 
strain (C57BL/6J, bg'bg), with impaired PMN function by deficiency of leukocytic 
neutral proteinases [11-13]. To exclude a contributory involvement of Мф in the 
early nephritic reaction we attempted to induce glomerular depletion of Мф by 
injection of clodro-L. 
Materials and methods 
Clodronate containing liposomes were prepared as described by van Rooijen and 
Sanders [7], using clodronate (dichloromethylene bisphosphonate) received as a gift 
from Boehringer, Mannheim GmbH, Germany. Since the effect of intravenously 
administered clodro-L is most prominently visible in liver tissue, in which it causes 
elimination of Kupffer cells [4, 7], we assessed the efficacy of the preparation by 
examination of liver sections of treated animals. Histologically, liver tissues, 
obtained at 24, 72, and 120 hr respectively after a single i.v. injection of 0.2 ml 
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clodro-L in otherwise untreated C57BL/6J mice, showed total destruction of Kupffer 
cells. This was confirmed by immunohistological staining of cryostat sections of 
fresh frozen liver tissues with peroxidase labelled monoclonal antibody F4/80 
(Serotec, Kidlington, England), that reacts with Kupffer cells and mature Μφ [14]. 
Staining was performed in a standard indirect immuno-peroxidase technique with 
diaminobenzidine as chromogen. The livers of the clodro-L treated mice showed a 
complete absence of F4/80 positive cells, whereas in control normal liver tissues the 
Kupffer cells were clearly positive. 
Induction of anti-GBM nephritis in mice by i.v. injection of rabbit anti-GBM 
antibody was performed as described before [9-11]. Μφ depletion was induced by 
/.v. injection of the clodro-L preparation in a dose of 0.2 ml at day -2 and -1 before 
the injection of anti-GBM antibodies. The development of the nephritic reaction was 
studied as previously reported [9-12]. Albuminuria was measured by radial 
immunodiffusion in 18 hr urine samples, collected during confinement of the animals 
in individual metabolic cages. Histological and immunohistological changes in the 
glomeruli were studied at 2 hr and 24 hr after injection of anti-GBM antibody. 
Glomerular accumulation of PMN was studied histologically (Periodic acid Schiff 
stain), and quantitated as mean numbers of PMN counted in at least 40 glomeruli in 
five mice per group. For counting of Μφ, with their less characteristic morphology, 
immunohistological identification of the cells is necessary. For optimal staining of 
the sporadically present glomerular Μφ we used a three step avidin-biotin technique, 
in which cryostat sections were incubated with the novel and highly sensitive rat 
anti-mouse monoclonal antibody FA/11, received as a gift from Dr. Michael Smith, 
Medical Research Council, Cambridge, England. This antibody reacts with an 
intracellular membrane sialoprotein confined to cells of the Μο/Μφ lineage [15]. As 
secondary antibody biotinylated goat anti-rat IgG was used, followed by standard 
ABC staining (Vectastain ABC, Vector Laboratories, Burlingame, California, USA). 
Glomerular Μο/Μφ were counted in five mice per group as described above. All 
experiments were designed and performed in accordance with institutional 
guidelines. 
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Results 
The effects of clodro-L treatment on circulating cells and on the development of anti-
GBM nephritis in C57BL/6J mice are summarized in Table 1. In clodro-L treated 
mice both the albuminuria and the glomerular damage at day 1 after injection of anti-
GBM antibody, comprising intravascular coagulation, endothelial cell damage, and 
necrosis, were significantly reduced. The number of glomerular Μφ was not 
affected, while glomerular PMN accumulation was markedly reduced. In the 
peripheral blood of clodro-L treated animals the absolute numbers of monocytes and 
PMN, counted at 24 hr after induction of the nephritis, were increased to more than 
two times the control values (Table 1). In the livers of all clodro-L treated animals 
Kupffer cells were completely destroyed during at least five days. When we repeated 
the experiments in beige C57BL/6J mice (C57BL/6J, bg'bg), a congenie mutant that 
is genetically deficient for leukocytic neutral proteinases, but has normal Μφ 
function [13], we obtained completely comparable results with regard to histological 
damage, and PMN and Μφ counts in the glomeruli and in the circulation. The early 
albuminuria was absent in this strain (data not shown), which is consistent with our 
earlier findings [12]. 
Discussion 
Of the methods used for selective depletion of Μο/Μφ most are insufficient with 
regard to effectivity and selectivity [1-3]. An obvious approach would seem to effect 
depletion by injection of specific antibodies. Apart from general problems with the m 
vivo use of antibodies such as short duration of the effect, modulation of the antigen, 
and an immune reaction against the foreign protein, the fact that Μο/Μφ and PMN 
share a common progenitor cell, and therefore many antigenic determinants, makes it 
difficult to induce a depletion of one cell line without affecting the other. The same 
goes for total body irradiation that clearly affects all leukocytes, while administration 
of 89Sr, apart from affecting PMN numbers, has been reported to induce depletion of 
circulating Mo without affecting tissue Μφ [16]. Methods based on the special 
phagocytic potential of Μφ, such as administration of silica, asbestos, or 
carrageenan, give incomplete depletion and/or undesired effects [1]. 
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Table 1. Summary of effects of clodro-L" treatment on nephritic reaction in C57BL/6J 
mice after induction of anti-GBM nephritis2', and on circulating leukocytes and Kupffer cells 
Albuminuria f^ g/l 8 hr) 
Glomerular damage 
Glomerular Μο/Μφ4) 
Glomerular PMN 4) 
Blood leukocytes 
differential count 
Kupffer cells in liver at day 
at day 13> 
at day 1 
at 2hr 
at 24 hr 
at 2 ru­
ât 24 hr 
xirrVl6) 
PMN (%) 
monocytes (%) 
-1 to +5 7) 
Controls 
14,873 ± 9504 
severe 
0 5 ± 0 15) 
0 7 ± 0 2 
60± 1 2 
0 1 ±0 1 
4900 ±1200 
17±4 
1±1 
intact 
Clodro-L pretreated 
4361±1492' 
minimal 
0 7 ± 0 2 
0 5 ± 0 1 
1 5 ± 0 4" 
0 1 ±0 1 
13,600 ±3200 
14 ±5 
2 ± 1 
destroyed 
1) Clodronate (dichloromethylene bisphosphonate) containing liposomes were given in 
doses of 0 2 ml л . at day -2 and -1 before the induction of nephritis 
2) Anti-GBM nephritis was induced by i ν injection of rabbit anti-mouse GBM antibody 
3) Albuminuria was measured in urine samples collected after confinement of mice in 
individual metabolic cages from 6-24 hr after injection of the anti-GBM antibody (n=5) 
4) Glomerular cells are given as the mean number per glomerulus ± SD, after counting of 
cells in at least 40 glomeruli per mouse (n=5), at 2 hr and 24 hr after injection of the anti-
GBM antibody 
5) Glomerular ΜοΜφ in normal untreated mice 0 5 ± 0 1 (n=5) 
6) Counted 24 hr after injection of anti-GBM antibody, ± SD 
7) Histological and immunohistological examination of liver sections at day -1 to 5 after 
administration of clodro-L 
* p< 0 02 compared with controls 
** p< 0 01 compared with controls 
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The use of clodro-L treatment is a more sophisticated technique that is applied in an 
increasing number of fundamental studies. It is assumed to affect functional Μφ in 
the later stages of differentiation, inducing "suicidal" phagocytosis of the clodronate 
loaded liposomes [2, 7]. In our model we used this method in an attempt to eliminate 
glomerular Μφ, without affecting PMN accumulation. 
An explanation for the failure of clodro-L to reduce the glomerular Μφ numbers 
might be that the liposomes are not able to cross vascular barriers and cannot pass 
the fenestrae (40-65nm wide) between capillary lumen and mesangial matrix. Indeed, 
on the basis of this hypothesis we expected to find no effect of clodro-L treatment in 
this pilot study. Therefore, the finding that clodro-L treatment inhibited the 
inflammatory reaction, with a reduction of PMN accumulation (Table 1), instead of a 
decrease of glomerular Μφ, was surprising, even more so in view of the increase of 
PMN in the circulation, a phenomenon also described by others [6,7]. Clodro-L are 
ingested by only a very small minority of PMN, and it has been reported that these 
cells are not affected by clodronate treatment, neither morphologically nor 
functionally in vivo or m vitro [7, 8]. Theoretically, circulating PMN could be 
mobilized from the bone marrow to the sites at which phagocytosis of the clodro-L 
takes place, chemotactically attracted to these sites by mediators released during the 
process of phagocytosis or cell necrosis. This would also explain an increase of 
circulating PMN. However, we found no increased numbers of PMN in the liver 
sections after destruction of the Kupffer cells. Likewise, Huitinga et al. [5] did not 
report an increase of PMN accumulation at the sites of inflammation in their 
encephalitis model. Possibly the local inhibition of PMN accumulation at the 
inflammatory site is caused by a decreased release of inflammatory mediators by the 
damaged Μφ. It has been shown that clodronate inhibits Μφ cytokine production in 
partially damaged Μφ [17]. In our model we thus far assumed that the PMN 
accumulation is directly related with binding of the Fc receptors to the Fc fragment 
of the GBM- bound antibody. The mechanism by which clodro-L treatment reduces 
glomerular PMN accumulation, despite an increase of circulating PMN, and in the 
absence of a reduction of glomerular Μφ, remains to be studied. Whatever this 
mechanism may be, the effect on glomerular PMN accumulation makes the method 
of clodro-L treatment unsuitable for the assessment of a possible role of Μφ in our 
PMN dependent model. 
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In conclusion, treatment with liposome encapsulated clodronate can be a valuable 
method for selective depletion of tissue Μφ, especially in experimental methods that 
concentrate on involvement of these cells in inflammatory reactions and host defense 
mechanisms. The results in our mouse model, however, show that in experimental 
systems in which PMN are essentially involved, clodro-L treatment may have an 
indirect effect on PMN accumulation, and is therefore not a suitable method to study 
possible contributory effects of Μφ. 
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Abstract 
To study the effector mechanisms operative in the autologous phase of anti-
glomerular basement membrane (GBM) nephritis in mice, the accelerated variant of 
this phase was developed in this species. C57BL/6J mice were injected i.v. with a 
subnephritogenic dose of rabbit anti-mouse GBM antibodies 7 days after 
preimmunisation with normal rabbit Ig. Albuminuria was assessed on days 1,2,3,4,8, 
and 15, and the morphological changes were evaluated by light microscopy, and 
immunohistology at days 1,2,3, and 8. A massive albuminuria developed already at 
day 1 (21,625 ± 4975 μg/18 hours), and persisted throughout the entire observation 
period. At day 1 there was also an increased glomerular influx of polymorphonuclear 
granulocytes accompanied by intravascular coagulation and endothelial cell swelling 
or necrosis. No evidence for involvement of macrophages was found. The 
accelerated autologous phase of anti-GBM nephritis in mice appears to be a stable 
and reproducible model of anti-GBM nephritis, and is therefore suitable for the study 
of the sequence of events that ultimately leads to loss of permselectivity and 
glomerular damage. 
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Introduction 
Previously we have studied the heterologous phase of passive anti-glomerular 
basement membrane (GBM) nephritis in the mouse, which is characterized by an 
acute and massive albuminuria (1), that is polymorphonuclear granulocyte (PMN) 
dependent but complement independent (2,3). Furthermore, we have shown that 
different mediator systems are involved in the early and late heterologous phase. The 
early albuminuria is dependent on leukocytic neutral proteinases (4,5), whereas the 
enhanced glomerular permeability and morphological damage later on is largely 
dependent on the action of reactive oxygen metabolites derived from activated PMN 
(6). Thus far we have not been able to demonstrate a role for macrophages in the 
heterologous phase in mice (4,6). This is in accordance with the findings in the 
heterologous phase in rabbits (7). By contrast, in rats macrophages seem to be 
important mediators (8). 
Our aim was to establish a reproducible variant of the autologous phase of anti-GBM 
nephritis in mice, the so-called accelerated autologous phase. In the rat and the rabbit 
this has proven to be a more stable model than the non-accelerated model, since it is 
not dependent on the variable response of the host to the administered heterologous 
anti-GBM antibodies (9). As in the rat and the rabbit, the accelerated autologous 
phase in mice was induced by the administration of a subnephritogenic dose of rabbit 
anti-mouse GBM antibodies (RaMGBM) to mice previously preimmunized with 
normal rabbit immunoglobulins (Ig). 
Methods. 
Animals 
C57B1/6J mice, originally obtained from Harlan Olac (Bicester, Oxon, England) 
were kept in our laboratory by continuous brother sister matings. For all experiments 
we used 3-6 months old animals weighing 20-25 g, with age and sex matched 
controls. New Zealand White rabbits, used for the preparation of the anti-GBM 
antibodies, were bought from a local breeder. 
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Anti-mouse GBMantibodies 
Rabbit anti-mouse GBM (RaMGBM) was prepared, purified, and assessed for purity 
and specifity as described before (1,2). The Ig concentration of the final preparation, 
determined by radial immunodiffusion (10) was 25 mg/ml. Normal rabbit Ig (nRalg) 
was prepared likewise, the Ig concentration of the final preparation was 20 mg/ml. 
Experimental protocol 
The accelerated autologous phase was induced by the i.v. administration of a 
subnephritogenic dose of RaMGBM (0.2 mg) in C57B1/6J mice preimmunised 6K2 
days before induction of the nephritis with 0.2 mg of nRalg administered i.p. with 
complete Freund's adjuvans (1:1 vol/vol, 0.2 ml total volume). Albuminuria was 
determined at days 1, 2, 3, 8, and 15, after the i.v. administration of RaMGBM, in 
groups of 5 to 9 mice. The urine samples for the determination of albuminuria were 
obtained by placing the animals in individual metabolic cages during 18 hr at the 
indicated day after i.v. injection of RaMGBM (1). The urinary albumin 
concentrations were measured by radial immunodiffusion using goat anti-mouse 
albumin antibodies (1,2). After the containment in metabolic cages, three mice of 
each group were bled at days 1, 2, 3, and 8 to assess the mouse anti-rabbit Ig 
antibody response by ELISA (serial dilutions). The kidneys of these mice were 
processed for histology and immunohistology. The albuminuria of the accelerated 
autologous phase was compared with that occurring during the heterologous phase 
and the following non-accelerated autologous phase, that was induced in control 
C57BL/6J mice by i.v. injection of RaMGBM in a nephritogenic dose (1 mg in 0.3 
ml). In this experiment, albuminuria was determined in groups of 4 mice at days 1 to 
6, days 8, 9, and 14. No histological examinations were performed in these groups. 
Histology and immunohistology 
For light microscopy (LM), tissue fragments from the kidneys were fixed in Bouin's 
solution, dehydrated, and embedded in paraplast (Amstelstad B.V., Amsterdam, The 
Netherlands). Four pm sections were stained with periodic acid Schiff (PAS) and 
silver methenamine (1). For immunofluorescence (IF), kidney fragments were snap 
frozen in liquid nitrogen, and 2 μπι cryostat sections were stained with FITC-labelled 
swine anti-rabbit Ig, rabbit anti-human fibrinogen that crossreacts with mouse 
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fibrinogen (DAKO, Copenhagen, Denmark), sheep anti-mouse Ig, heavy and light 
chains (Cappel Laboratories, West Chester, USA) and goat anti-mouse C3 (Nordic, 
Tilburg, The Netherlands). The number of PMN per glomerular cross section were 
determined by LM in PAS-stained slides. The number of glomerular macrophages 
were determined immunohistologically on 5 μτα cryostat kidney sections, after 
staining with the rat anti-mouse macrophage monoclonal antibody F4/80 (Serotec, 
Kidlington, England) in a standard immunoperoxidase method, with 
diaminobenzidine as chromogen. Glomerular PMN and macrophage counts were 
performed in at least 40 glomeruli per mouse and expressed as the mean per 
glomerular cross section. For IF, the sections were examined in a Leitz fluorescence 
microscope and the staining intensity of glomerular deposits was recorded 
semiquantitatively on a scale from zero to 4+ as described before (1). Tissue 
fragments taken from kidneys of normal, non-nephritic mice (n=5) were used as 
controls. 
Statistical Analysis. 
For statistical analysis, Wilcoxon's rank sum test was used. 
Ρ values <0.05 were considered significant. All values are expressed as means ± SD. 
Results 
Albuminuria 
All animals tolerated the induction of the nephritis well. Figure 1 shows the 
albuminuric response in C57BL/6J mice preimmunized with nRIg in which the 
nephritis was subsequently induced by the i.v. administration of a subnephritogenic 
dose (0.2 mg) of RaMGBM. Albuminuria was massive at 24 hr after induction of the 
nephritis (21,625 ± 4975 μg/18 hr vs 90 ± 45 μg/18 hr in control mice), increased at 
day 2 (27,675 ± 9850 μg/18 hr) and slightly decreased thereafter, remaining 
significantly elevated throughout the entire observation period of about two weeks 
(Figure 1). The albuminuria in the accelerated autologous phase is considerably 
higher than the albuminuria in non-preimmunized mice that received a nephritogenic 
dose (1.0 mg) of the same RaMGBM preparation (Figure 1). 
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mg/18 hours 
40 ι 
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day 
Figure 1. Albuminuria in preimmunized C57BL/6J mice after injection of a low, 
subnephritogenic dose of anti-GBM antibody (0 2 mg) (•) For comparison the albuminuria 
in non-preimmunized mice after injection of a nephritogenic dose (1 0 mg) of antibody, i.e. a 
standard heterologous phase, is also shown (&) 
Histology and Immunofluorescence 
Morphologically, the accelerated autologous phase was characterized by influx of 
PMN that was maximal at two hr after injection of the anti-GBM antibody. This 
glomerular influx of PMN returned to normal levels in about four days (Table 1). At 
two hr glomerular endothelial cell swelling and protein casts in the tubuli were also 
present, whereas no thrombosis or cell necrosis was discernible. At 24 hr 
intravascular coagulation could be observed in the glomeruli, along with increased 
endothelial cell swelling and necrosis. At days 2, 3, and 8 progressive damage to the 
glomeruli was apparent, with severe necrosis and thrombosis, and sometimes 
proliferation of mesangial cells, while in 10% of the glomeruli small crescents had 
developed (Figure 2). No increase of macrophages could be demonstrated in the 
glomeruli at any time during the observation period (Table 1). By IF the heterologous 
anti-GBM antibodies and the autologous (mouse) anti-rabbit Ig antibodies bound to 
the GBM in a linear fashion (Figure ЗА and B). A fine granular deposition of C3 was 
observed along the capillary wall (Figure 3C). Fibrin deposits could be observed with 
increasing intensity in the majority of the glomeruli during the course of the disease 
(Figure 3D). 
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Table 1. Glomerular PMN and macrophage counts, and immunofluorescence 
findings after the injection of anti-GBM antibodies in preimmunized C57BL/6J mice. 
Time after 
RaMGBM 
Immunofluorescence 
PMN Μ Φ ' RaMGBM mlg ' C3 Fibrin 
2 h 
1 day 
2 days 
3 days 
8 days 
2 
3 
3 
3 
3 
3.4±0.3 
2.4±0.7 
0.9±0.1 
0.6±0.2 
0.3±0.2 
0.2±0.1 
0.3±0.1 
0.5±0.1 
ND 
0.4±0.1 
ND ND 
M M ' 
ND 
++Г 
N D 
++ 
++ 
++ 
+-H-
" PMN and МФ were counted in at least 40 glomeruli per mouse and are given as 
mean numbers per glomerulus (in normal, non-nephritic controls: 0.2±0.1) 
4
 mean glomerular macrophage ((in normal, non-nephritic controls: 0.5±0.3) 
c
 RaMGBM: rabbit antimouse GBM antibodies 
d
 mlg: mouse immunoglobulin 
' linear staining along the capillary wall 
1
 fine granular deposits in the capillary wall 
ND denotes not done 
Figure 2. Glomerulus with a 
prominent crescent (asterisk, χ 
800), eight days after induction 
of the accelerated autologous 
phase of anti-GBM nephritis. 
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Figure 3. Immunofluorescence findings in glomeruli at day 8 after induction of the 
nephritis. Linear binding of the heterologous rabbit antibodies (A) and autologous 
antibodies (B) to the capillary wall, accompanied with granular deposits of C3 (C). 
Massive accumulation of fibrin is present in many capillary lumina (D). χ 800. 
Discussion 
The present study was undertaken primarily to develop a reproducible model of 
accelerated autologous anti-GBM nephritis in the mouse. A non-accelerated 
autologous phase of anti-GBM has been described by Unanue et al in both 
complement normal and C5 deficient mice (11). In that study albuminuria was not 
measured quantitatively, and no mention was made of whether PMN or macrophages 
were involved. The accelerated autologous phase in the mouse has been described as 
part of a larger study by Nagai et al (12), and, briefly, in an abstract by Holdsworth 
et al (13), without quantification of the albuminuria and without extensive 
histological examination. In the present study we found a massive albuminuria, that 
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persisted throughout the entire observation period of 15 days. The influx of PMN at 
two hr after the induction of the nephritis was somewhat less than that found in the 
heterologous phase (3.4 ± 0.3 vs 6.0 ± 0.5 (6)). The influx of PMN in the glomeruli 
subsided more slowly than in the heterologous phase (1) returning to normal levels 
after three days, while in the heterologous phase the PMN counts return to normal 
within 24 hr (1). Unexpectedly, in this model no increase of glomerular macrophages 
could be demonstrated during the first eight days after induction of the nephritis, 
whereas in rabbits and rats, a prominent recruitment of these cells is a characteristic 
feature (7,8). The histological findings are consistent with those reported by Unanue 
el al. (11), and comparable to those in the heterologous phase, although the damage 
to the glomeruli is more extensive in the accelerated autologous phase. On day 8 
crescent formation was observed in about 10% of the glomeruli. This finding was 
recently reported by another group (13), that found crescent formation in C57BL/6J 
mice at 10 days after the induction of the nephritis. 
Since the sequence of events in the accelerated autologous phase of anti-GBM 
nephritis resembles qualitatively those of the heterologous phase, it is tempting to 
speculate that similar effector mechanisms are operative in the induction of the 
albuminuria and the morphological damage in both phases. We found previously that 
the heterologous phase in mice was dependent on the early glomerular accumulation 
of PMN (3) and not on complement activation (2), despite the deposition of C3 in the 
glomerular capillary wall. Depletion studies are necessary to explore the role of 
PMN and complement in the induction of glomerular injury in this model. From our 
findings that macrophages did not increase at any time we derive that they are not 
involved in the induction of the albuminuria and the morphological damage. This is 
at variance with the findings in rats and rabbits, in which the inflammatory response 
in the glomerulus is particularly dependent on the presence of macrophages (7,8). It 
is important to note that the influx of macrophages in the glomeruli in rats and 
rabbits was preceded by a mild accumulation of PMN. There is one report that 
mentions a role for PMN in the induction of glomerular injury in the autologous 
phase. By depleting PMN with nitrogen mustard and with specific anti-PMN 
antibodies Naish et al found a substantial reduction of glomerular damage and a 
protection of renal function in rabbits (14). 
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In conclusion, the accelerated autologous phase of anti-GBM nephritis in mice is a 
stable, reproducible model of glomerulonephritis, that can be used to study the 
mediators involved in the pathogenesis of glomerulonephritis in the mouse. This 
mouse model is especially attractive for studies in newly available genetically 
manipulated animals, which will make it possible to study the different mediator 
systems selectively. 
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ABSTRACT 
Macrophages have been shown to mediate glomer­
ular Injury In antiglomerular basement membrane 
(antl-GBM) glomerulonephritis in rats and rabbits. 
To evaluate the role of macrophages and the mac-
rophage-relaled cytokines, colony stimulating fac­
tor-1 (CSF-1), monocyte chemoattractant proteln-1 
(MCP-1) and RANTES, accelerated antl-GBM nephritis 
was studied In op/op mutant mice, which lack CSF-1 
and are severely macrophage deficient, and In het­
erozygous op/+ control mice. Observations were 
made 24 h and 3 days alter the Injection of rabbit 
anti-mouse GBM antibody in mice prelmmunlzed with 
rabbit Immunoglobulin G. Proteinuria rose progres­
sively in both groups but did not differ between them 
(urine protein/creatlnine ratio at 3 days: 1.01 ± 0.38 In 
op/op versus 1.45 ± 0.43 In op/+; P, not significant). In 
both op/op and opl+ mice, antl-GBM nephritis was 
associated with renal expression of mRNA for RANTES 
and MCP1! and barely detectable levels of mRNA for 
CSF-1. In contrast, these cytokines were no) expressed 
In sham-injected mice. Morphologic lesions ap­
peared earlier In op/op mice but were comparable 
by Day 3. Glomerular Injury consisted of capillary 
thrombosis and endothelial cell damage associated 
with mild to moderate leukocyte Infiltration. Despite 
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enhanced expression of mRNA for RANTES and MCP-1, 
glomerular macrophage Infiltration was not In­
creased In opl+ mice. It was concluded that, In mice, 
In contrast to rats and rabbits, accelerated antf-GBM 
nephritis may develop In the absence of both CSF-1 
and macrophage infiltration. 
Key Words Antiglomerular basement membrane nephrite, 
experimental glomerulonephritis, macrophages, colony stim­
ulating factor-! 
M acrophages play a key role In mediating glomer­ular injury In antiglomerular basement mem­
brane (anti-GBM) glomerulonephritis in the rabbit 
and rat. The complement-Independent autologous 
phase of antl-GBM nephritis in these species is char­
acterized by extensive glomerular macrophage accu­
mulation resulting from an influx of circulating mono­
cytes (1-13) Glomerular macrophages are locally 
activated to elaborate chemotactlc peptides, cyto­
kines, proteolytic enzymes, and olher inflammatory 
mediators (1.7.9,14) When glomerular macrophage 
Infiltration is prevented by monocyte depletion, pro­
teinuria and morphologic injury are ameliorated [2.4-
6,8.9). 
The chemotactlc factors responsible for comple­
ment-independent glomerular macrophage Influx and 
activation In anti-GBM nephritis are unknown Sev­
eral monocyte-speclflc cytokines synthesized by 
mesangial cells are potential candidates, including 
colony stimulating factor (CSF-1 ). monocyte chemoat­
tractant protein (MCP-1), and RANTES (regulated 
upon activation, normal Τ cell expressed and secreted) 
(15.16). 
In view of the critical role of macrophages In antl-
GBM nephritis. It was of interest to study this disease 
in the op/op mouse, a mutant strain that lacks CSF-1 
because of a mutation on chromosome 3 within the 
gene coding for CSF-1 (17-19) The absence of CSF-1 
results in severe deficiencies of bone marrow macro­
phages, blood monocytes, tissue macrophages, and 
osteoclasts (17-19). We postulated that the op/op 
mouse would be an Ideal model In which to study the 
roles of CSF-1 and of macrophages In mediating glo­
merular injury In antl-GBM nephritis. 
METHODS 
Production of Anti-Mouse GBM Antibodies 
GBM was prepared from Swiss mouse kidneys (Central 
Institute for the Breeding of Laboratory Animals. TNO. Zeist. 
the Netherlands) by a differential sieving technique, followed 
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by sonicatíon and detergent treatment as previously de 
scribed (20) Antisera against this basement membrane sus 
pension were raised in rabbits The pooled ал tisera were 
heated at 56°C for 45 min and the immunoglobulin G (IgG) 
fractions were purified by affinity chromatography on a 
Sepharose 4B coupled protein A column (Pharmacia Upp 
sala Sweden) The IgG antibodies were concentrated by 
ultrafiltration with an XM 50 Dlalow membrane (Amlcon 
Corp Lexington MA) sterilized by passage through a sterile 
0 2 μπι pore size filter and stored at -30"C The IgG con 
centrât Ion was measured by the radial Immunodiffusion 
technique 
Induction of Anti-GBM Nephritis 
Antl GBM nephritis was induced In 12 to lb wk old male 
op/ + mice (JV = 10) and op/op mice IN = 10) Animals were 
obtained from an established colony (17 19) Seven days 
before the administration of antl GBM antibody the mice 
were prelmmunlzed with 0 2 mg of normal rabbit IgG admin 
Istered Ip with complete Freunds adjuvant (1 1 in a total 
volume of 0 2 mL) Nephritis was then Induced by the iv 
Injection of rabbit antl mouse GBM antibody (0 2 mg In a 
total volume of 0 3 mL) Four nephritic mice In each group 
were euthanized after 24 h and six additional nephritic mice 
In each group were euthanized at 3 days Other op/+ and 
op/op mice (Ñ * 2 In each group) were prelmmunlzed in an 
identical manner sham injected with 0 3 mL of NaCl and 
euthanized 3 days later Additional primmunlzed op/+ and 
op/op mice were sham Injected with normal rabbit IgG (0 2 
mg in a total volume of 0 3 mL) [N = 4 in each group) 
Proteinuria did not differ between sham injected mice given 
saline versus normal rabbit IgG and these data were com 
blned 
Clinical Parameters 
Beginning 7 days before the administration of saline or 
antl GBM antibody and continuing until the day of euthana 
sla dally urine specimens were obtained from mice for the 
determination of the urine protein /creatinine ratio (UP/UCr) 
as an index of urinary protein excretion Urinary creatinine 
was measured by the Jaffe reaction and urinary protein was 
measured by the Bio Rad Protein Assay (Bio Rad Richmond 
CA) Animals were euthanized 24 h or 3 days after iv antl 
GBM antibody or sham Injection Blood was collected at the 
time of euthanasia for the measurement of BUN serum 
creatinine and white blood cell count 
Antl rabbit IgG antibody activity was determined In mouse 
serum by ELISA (21) Measurements were made in serial 
dilutions in the measurable range and expressed In relative 
absorbance units 
Light Microscopy 
Kidneys were harvested and the right kidney was decap 
sulated sectioned In the coronal plane and fixed In Bouln s 
solution (Sigma Chemical Co St Louis MO) Fixed kidney 
sections were dehydrated and embedded In paraptast (Ams 
telstad Amsterdam The Netherlands) and 4 μιπ sections 
were stained with hematoxylin and eosln silver methena 
mine and periodic acid Schiff The glomerular Influx of 
polymorphonuclear leukocytes (PMN) was determined by 
counting PMN in at least 40 glomerull/mouse and was 
expressed as the average number of PMN/glomerulus 
Immunohistology 
Kidney fragments were snap frozen in liquid nitrogen and 
2 to 4 м т cryostat sections were Incubated with monospe 
ciflc fluorescein labeled goat antl mouse Ig (heavy and light 
chains) and goat antl mouse C3 serum (both from Cappel 
Laboratories West Chester PA) goat antl rabbit lg (Nordic 
Tilburg The Netherlands) absorbed with 500 mg/mL of 
lyophlllzed nonimmune mouse serum and rabbit antl hu 
man fibrinogen cross reacting with mouse fibrinogen (Dako 
Copenhagen Denmark] The sections were examined In a 
fluorescence microscope equipped with epl illumination 
(Leltz Wetzlar Germany) and the staining Intensity was 
recorded semlquantllallvely (grading 0 to 4+) as previously 
described (20) 
The number of glomerular macrophages was determined in 
5 μπι frozen kidney sections with the rat antl mouse macro 
phage monoclonal FA/11 (22 23) (kindly donated by Dr 
G L E Koch MRC Laboratory of Molecular Biology Cam 
bridge United Kingdom) as the first antibody a three step 
avldln blotln technique with blotlnylated goat antl rat IgG 
(Vector Laboratories Burllngame CA) (24) as secondary 
antibodies and finally alkaline phosphatase Vectastaln ABC 
(Vector Laboratories) The number of macrophages was as 
sessed as the mean number per glomerular cross section 
counted In at least 40 glomeruli 
Electron Microscopy 
For electron microscopy small pieces of cortex were fixed 
In 2 5% glut arai deny de (Sigma) dissolved In 0 1 M sodium 
cacodylate (Sigma) buffer pH 7 2 for 4 h at 4"C and washed 
in the same buffer The tissue fragments were postflxed In 
phosphate buffered 2% O s 0 4 (Johnson Matthey Chem Roy 
stone United Kingdom) for 2 h dehydrated and embedded 
In Epon Θ12 (Merck Darmstadt Germany) Ultralhln sec 
lions were cut In an ultratome (LKP Produkter Brom ma 
Sweden) and stained with 5% uranyl acetate for 45 min and 
with lead citrate for 2 min at room temperature The sections 
were examined In an electron microscope (ELMISKOP 101 
Siemens Berlin Germany) 
Northern Blot Analysis 
mRNA levels of RANTES CSF 1 and MCP I were evalu 
ated on Days 1 and 3 In control and nephritic animals Total 
RNA was extracted from the left kidney and samples of 10 Mg 
were then used for northern blot analysis After electrophore 
sis on a 1% agarose gel the RNA was transferred to nylon 
filters Labeling οΓ the cDNA probes specific for CSF 1 
MCP 1 RANTES GAPDH and 18S rlbosomal RNA was 
accomplished by random prime transcription with |32P)dCTP 
(16 25 26) Nylon filters were prehybrldized (65°C l t o 3 h ) l n 
a solution containing 1 M NaCl and 1% sodium dodecyl 
sulfate and were then hybridized with the labeled cDNA 
probes for 16 h After the filters were washed to high 
stringency (0 IX SSPE (150 mM NaCl 10 mM NaH 2 P0 4 1 
mM EDTA pH 7 4] 1% sodium dodecyl sulfate) autoradlog 
raphy with Intensifying screens (-70 eC) was performed 
Hybridization of the specific mRNA was quantità ted by laser 
densitometry and results were normalized to the respective 
GAPDH bands All studies were conducted In accord with the 
NIH Guide for the Care and Use of Laboratory Animals 
Statistical Analysis 
Data are expressed as the mean ± SE Values were com 
pared with the f test for paired or unpaired data or analysis of 
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variance with SheíTe's correction Statistical significance was sham-Injected op/ + mire were undetectable on Days 
dellned as Ρ < 0 05 1 and 3 
RESULTS 
Clinical Parameters 
Body weight was lower In op/op mice than In op/ + 
mlce at the time of entry Into the study (32 ± 2 versus 
23 ± 4g. P < 0 01) In sham-Injected op/op mice (N = 
6). the baseline UP/UC r x 10. calculated as the aver­
age of dally values obtained on 7 days before sham 
injection, was 0 15 ± 0 04 U P /U C r averaged 0 12 + 
0 03 over the 3 days after the injection (P. not signif­
icant [NS] versus baseline) (Figure 1) In sham-in-
Jected op/ + mice (N = 6). UP/UC r was 0 21 ± 0 05 
during the week before sham Injection and 0 23 ± 
0 06 after (P, NS versus baseline) At each time before 
and after sham injection, proteinuria was greater In 
op/+ mice than In op/op mice (P < 0 05) 
Baseline U
r
/U C r , calculated as the average of dally 
values obtained on 7 days ЬеГоге the administration of 
rabbit antl-GBM antibody, was again higher In opl + 
than In op/op (0 17 ± 0 03 In op/ + versus 0 09 i 0 02 
in op I op. Ρ < 0 05) (Figure 1) UP/UC r did not differ 
between the two groups when measured 24 and 48 h 
after the administration of antl-GBM antibody (Figure 
1) At the time of euthanasia on Day 3. U P /U C r was 
101 ± 0 38 In op/op versus 1 45 ± 0 43 In op/ + . P. 
NS In both nephritic groups, proteinuria was signifi­
cantly greater than baseline values (P < 0 001 at 48 
and 72 h palred t test) and also significantly greater 
than values In the corresponding sham-Injected 
groups (P < 0 01 at 48 and 78 h) 
Serum creatinine did not differ among the groups at 
the time of euthanasia (data not shown) Serum anti-
rabbit antibody titer, measured 24 h after the admin­
istration of rabbit anti-mouse GBM antibody, was 90 
± 8 in op I op versus 95 ± 7 in op/+ (P. NS) When 
measured 3 days after the administration of antl-GBM 
antibody, serum antl-rabblt antibody titer was 93 ± 6 
In op I op versus 215 i 55 In op/+ (P < 0 05) Serum 
antl-rabblt antibody titers In sham Injected op/op and 
mRNA 
Several Immune-mediated glomerular diseases 
have been associated with changes In the expression 
of leukocyte-activating cytokines such as CSF-1, 
MCP-1. and RANTES (27-32) We therefore performed 
northern blot analysis on RNA extracted from whole 
kidneys harvested from our experimental animals As 
shown In Figure 2, sham-Injected op/op IN = 2) and 
op/+ (N = 2) contained no detectable mRNA for 
CSF-1, MCP-1, or RANTES, but had comparable levels 
of mRNA for the constitutionally expressed GAPDH In 
contrast, kidneys from antl-GBM-lnJected op/op and 
op/+ mice expressed detectable levels of mRNA for 
RANTES and MCP-1 at 24 and 72 h after the Induction 
of glomerulonephritis Levels for CSF 1 were barely 
detectable No consistent differences In the expression 
of RANTES or MCP-1 were detectable by inspection or 
densitometry of the northern blots between op lop and 
op/+ mice after 24 h (four mice examined per group) 
or after 72 h (six mice examined In each group) In 
fact, mRNA levels for RANTES tended to be higher In 
op/op mouse kidneys Thus, antl-GBM nephritis In 
both op/op and op I + mice Is associated with the renal 
expression of mRNA for RANTES and MCP-1 In con­
trast, neither of these cytokines nor CSF-1, Is ex­
pressed In control, sham-injected mice 
Morphology 
Light Microscopy and Electron Microscopy. In the 
op/op group, glomerular lesions were absent on Day 
1, whereas in the op/+ group minor to moderate 
damage could already be observed These lesions con­
sisted of segmental deposition of homogeneous or 
finely granular periodic acid Schiff positive material 
In the capillary loops. Intravascular coagulation en­
dothelial cell damage, and necrosis At Day 3, glomer­
ular damage was now more extensive and Identical in 
both groups (Figure 3) At this time, occasional epl-
1.35 
Urinary Protein/ 
Creatinine Ratio 0.Θ 
(mg/ml/mo/dl) 
0.45 
GN op/« 
Pre 24 48 
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Figure 1 Proteinuria In sham-Injected and antMSBM antibody-Injected op/+ and op/op mice 
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Anti-GBM Ab SHAM 
Figure 2. Steady-state mRNA for CSF-1, RANTES. MCP-1, and 
GAPDH in total RNA extracted from the whole kidneys of 
sham-injected and anti-GBM antibody (Ab)-injected op/op 
and op/+ mice. Comparable results were obtained in four 
experiments for Day 1, six experiments for Day 3, and two 
sham experiments. Kb, kilobase. 
thelial cell hypertrophy could also be seen. Sham-
injected op!op and op/+ mice did not show any 
glomerular lesions. 
The glomerular neutrophil infiltration in op/op mice 
was 0.5 ± 0.3 PMN/glomerular cross-section on Day 1 
and increased to 1.7 ± 0.9 PMN/glomerular cross-
section on Day 3. Although neutrophil infiltration in 
op/+ mice was greater on Day 1 than on Day 3, the 
intragroup variation was very large ( 1.9 ± 3 versus 0.7 
± 0.4 PMN/glomerular cross-section). Glomerular 
PMN accumulated predominantly in necrotic areas. 
Glomerular neutrophilic infiltration in sham-injected 
op/op and op/ + mice was low and comparable (0.2 ± 
0.0 versus 0.2 ± 0 . 1 PMN/glomerular cross-section, 
respectively). The glomerular lesions, especially the 
deposition of fibrin and endothelial cell damage, were 
confirmed at the electron microscopic level (Figure 4). 
Immunohistology. All kidneys showed strong linear 
staining of the GBM for rabbit and mouse IgG (3 + ) 
(Figure 5A and B). Fibrin deposits varied but paral­
leled roughly the segmental necrotic lesions seen by 
light microscopy (Figure 5D). C3 deposits were also 
variable (Figure 5C). In addition to minor mesangial 
deposits in all glomeruli, which is a normal finding in 
mice, more extensive C3 deposits could be observed 
along the glomerular capillary wall in a fine granular 
pattern and in the mesangial areas of several kidneys. 
Sham-injected mice of both strains showed only occa­
sional minor C3 and Ig deposits in the mesangium. 
Macrophages were barely detectable in the glomer­
uli of sham-injected op/'op mice (0.01 ± 0.02/glomer-
ular cross-section; N = 2) and in op/op mice 3 days 
Figure 3. Light microscopy of the glomerular damage in an 
op/op mouse 3 days after the Injection of rabbit anti-mouse 
GBM antibody. Identical lesions were present in op/+ mice. 
Extensive intravascular coagulation (arrowheads) accom­
panied by swelling and necrosis of endothelial cells can be 
seen. A few polymorphonuclear granulocytes (arrow) are 
located in a capillary loop (original magnification, χ 770). 
after the induction of nephritis (0.06 ± 0.03/glomer-
ular cross-section; N = 5). In op/+ mice, the number 
of glomerular macrophages at Day 3 was higher than 
in op/op mice (0.68 i 0.51/glomerular cross-section; 
N = 4) but did not exceed the number in normal mice 
(0.8 to 1.0 macrophages/glomerular cross-section; 
unpublished observation). 
DISCUSSION 
There is considerable evidence that glomerular in­
jury in the autologous phase of anti-GBM nephritis in 
the rat and rabbit is mediated by infiltrating glomer­
ular macrophages (1-13). In accelerated models of 
anti-GBM nephritis, macrophage infiltration of the 
glomerulus begins within 24 h after antibody admin­
istration and peaks within 2 to 3 days (3,6.8.11,12). 
The macrophage dependence of autologous-phase glo­
merular injury in rat and rabbit models has been 
demonstrated by experimental maneuvers that in­
duce monocytopenia (2,4-6,8,9). These maneuvers 
reduce glomerular macrophage Infiltration and ame­
liorate or prevent proteinuria and histologic abnor­
malities in the rat and rabbit (2.4-6,8.9). 
The op/op mouse carries a mutation on chromo­
some 3 within the gene coding for CSF-1 (17-19). As a 
result, the serum of op /op mice lacks CSF-1 (18). 
Normally, CSF-1 regulates the survival and prolifera­
tion of mononuclear phagocytes and is responsible for 
normal macrophage and osteoclast maturation (17-
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Figure 4. Electron photomicrograph of a glomerular capillary loop of ar¡ op/+ mouse 1 day after the administration of rabbit 
anti-mouse GBM antibody. Two polymorphononuclear granulocytes partly adhere to the inner side of the denuded GBM, 
replacing and destroying the endothelial cells. The foot processes of the visceral epithelial cell show signs of fusion (original 
magnification, χ 15,000). Abbreviations: Ept, visceral epithelial cell; End, endothelial cell. 
19). The absence of CSF-1 results in severe deficien­
cies of bone marrow macrophages, blood monocytes, 
tissue macrophages, and osteoclasts (17-19). Kidney 
tissue macrophages in op/op mice are reduced to 3% 
of the numbers present in op/ + mice at 2 months of 
age and to 28% of the numbers present in op/ + mice 
at 3 months of age (19). We postulated that the op/op 
mouse would be an ideal model in which to study the 
roles of CSF-1 and of macrophages in mediating glo­
merular injury in anti-GBM nephritis. 
Glomerular injury in our model of accelerated au-
tologous-phase anti-GBM nephritis occurred In op/op 
mice, despite the absence of CSF-1 and the absence of 
glomerular macrophage infiltration. Moreover, glo­
merular injury ín control op/+ mice also occurred in 
the absence of glomerular macrophage accumulation. 
These observations suggest that glomerular injury in 
the early autologous phase of murine anti-GBM ne-
phritis does not require CSF-1 or macrophage infiltra-
tion. However, we cannot exclude the possibility that 
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Figure 5. Immunofluorescence findings after the injection of rabbit anti-mouse GBM antibody In opl + mice. Similar results were 
found In op/op mice. (A) Linear binding of rabbit Ig to the GBM. (B) Identical binding of mouse Ig. (С) Fine granular deposits 
of C3 along the capillary wall with additional deposition in the mesangium. (0) Massive segmental deposits of fibrin mainly in 
the capillary lumina (original magnification, x510). 
the few macrophages present in the glomerulus, acti­
vated by the up-regulated glomerular chemokines, 
may have played a role in mediating renal injury. 
Mouse anti-rabbit antibody titer was significantly 
higher at Day 3 in op/+ mice injected with rabbit 
anti-rat GBM antibody than in similarly treated op/op 
mice. The finding of similar intensity of immunofluo­
rescence staining for mouse Ig in the glomeruli of 
op/+ and op/op mice, despite increased serum anti-
rabbit antibodies in op/+ mice, may be explained if 
glomerular binding sites for anti-rabbit antibody were 
saturated in both strains of mice during the autolo­
gous phase. Impaired antibody response in op/op 
mice is not surprising, ín view of the important role 
macrophages play in antigen processing and presen-
tation. Although the increased antibody response in 
op/+ mice was associated with earlier morphologic 
injury, by Day 3, the severity of glomerular injury was 
comparable ín both groups of mice. 
Monocyte-specific cytokines synthesized by me-
sangial cells, such as CSF-1, MCP-1, and RANTES, 
have been shown to play a role In mediating glomer-
ular injury in several experimental models of renal 
disease, including anti-GBM nephritis (28-32). How-
ever, In our studies, glomerular injury developed in 
CSF-1-deficient op lop mice. Moreover, macrophage 
infiltration did not increase in nephritic op/+ mice, 
despite enhanced renal expression of mRNA for the 
potent monocyte chemoattractants MCP-1 and RAN-
TES. Because we did not localize the source of the 
increased mRNA to glomeruli versus tubules, our 
observations do not necessarily reflect a dissociation 
between monocyte chemoattractant expression and 
biologic response. In addition, it is possible that an 
enhanced message for these cytokines was not trans-
lated into increased protein product. 
We conclude that, in contrast to the mechanisms 
operative in the rat and rabbit, glomerular injury in 
the autologous phase of anti-GBM nephritis can occur 
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1л the m o u s e in the a b s e n c e of glomerular macro­
phage Infiltration and in the a b s e n c e of CSF-1 
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Chapter 8 
Summary and conclusions 

The i.v. administration of anti-glomerular basement membrane (GBM) antibodies, 
and their consequent binding to the GBM, leads to the activation of various humoral 
and cellular mediators of inflammation which ultimately results in proteinuria and 
morphological damage (reviewed in 1). Previous studies in our passive anti-GBM 
nephritis model in the mouse, in which we concentrated upon the events during the 
first 24 hours after induction of the nephritis, revealed that the early glomerular 
damage and albuminuria is complement-independent but polymorphonuclear 
leukocyte (PMN)-dependent (2,3). This mechanism has not been described for other 
animal species, such as the rabbit and the rat, in which complement activation is 
essential for the recruitment of PMN in the glomerular tuft in the early heterologous 
phase of this model (1). Additional studies in beige mice, in which the PMN are 
deficient for the leukocytic neutral proteinases, disclosed several other interesting 
aspects with regard to the effector mechanisms involved in this model. First, the 
albuminuria, as measured in the first 24 hours after induction of the nephritis, is 
totally dependent on the effect of the leukocytic neutral proteinases, elastase and 
cathepsin G. Second, reactive oxygen metabolites (ROM) do not contribute to the 
induction of this early albuminuria (4). This is in contrast to the findings in the rat, in 
which ROM reportedly are involved in the induction of the albuminuria in the 
heterologous phase of anti-GBM nephritis (5). Our results are in line with findings of 
others showing that ROM do not directly attack the GBM, but do so indirectly by 
activating latent leukocytic proteinases and by degrading locally powerful inhibitors 
of these proteinases (6). 
To provide definitive proof that the lack of albuminuria in the beige mouse in the 
early phase of the passive anti-GBM nephritis was due to an intrinsic cellular defect 
of beige PMN and not to unknown local or systemic humoral factors possibly unique 
for the beige strain, we performed reciprocal bone marrow transplantations (BMT) in 
C57BL/6J, bg/bg (beige) mice and in congenie control C57BL/6J, +/+ mice. Beige 
mice reconstituted with control bone marrow developed an albuminuria comparable 
to that in C57BL/6J, +/+ nephritic mice. The reconstitution of beige bone marrow in 
control mice, on the other hand, resulted in an albuminuria that did not surpass the 
physiological level of normal beige mice. Reconstitution with syngeneic bone 
marrow demonstrated that the BMT procedure by itself did not have any effect on 
the level of albuminuria. After BMT with normal BM the beige mice had elastase 
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activities (as measured in PMN extracts) comparable to those measured in the donor 
mice. Morphologically, mice from all BMT groups in which the nephritis was 
induced, showed an identical influx of PMN in the glomeruli immediately following 
anti-GBM antibody administration, and similar endothelial cell damage with 
intravascular coagulation. From these experiments, it is concluded that the absence of 
early albuminuria in C57BL/6J, bg/bg mice is caused by their intrinsic defect in 
leukocytic proteinase activity (chapter 2). 
Studies of the heterologous phase usually comprise the first 24 hours after the i.v. 
administration of anti-GBM antibodies (1). As mentioned above, the heterologous 
phase is the period that starts with the immediate inflammatory response of the host 
to the heterologous anti-GBM antibodies fixed to the GBM and that ends with the 
appearance of the autologous host antibodies to the foreign antibody (autologous 
phase). Since beige mice do not develop the albuminuria in the early {i.e. first 24 
hours) heterologous phase, despite an uninhibited influx of PMN and the 
development of morphological damage comparable to that in the congenie control 
C57BL/6J, +/+ mice, we studied the sequence of events in the later days of the 
heterologous phase in beige mice. Quite unexpectedly, we found that beige mice 
developed albuminuria from day 2 on, that reached a level comparable to that of 
congenie nephritic controls on day 3. This late albuminuria proved to be 
complement-independent, but PMN and Fc-dependent. No increase in macrophages, 
CD4+ or CD8+ lymphocytes was detected. The morphological damage and 
albuminuria were greatly diminished by the administration of DMSO, a scavenger of 
hydroxyl radicals, which are highly reactive ROM. Thus, our original hypothesis that 
ROM cannot cause proteinuria in the heterologous phase of anti-GBM nephritis 
appeared to be correct with regard to the first 24 hours of this phase only. We 
conclude from our results that the heterologous phase is actually a biphasic process. 
The early albuminuria is dependent on the presence of leukocytic neutral proteinases, 
while the glomerular lesions and later occurring albuminuria are largely dependent 
on ROM, most likely derived from activated PMN. The possible involvement of 
other mediator systems, including those effected by resident glomerular cells which 
may be involved in the late heterologous phase, needs to be studied further (chapter 
3). 
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Both platelets and fibrin deposits have been implicated in the mediation of 
glomerular damage in several forms of human and experimental nephritis (7). 
Platelets, which contain numerous potent inflammatory mediators, can be involved in 
the induction of proteinuria and morphological lesions, while fibrin may particularly 
mediate the development of crescents (8-10). Because of the prominent intravascular 
coagulation seen in the anti-GBM model, we have investigated the role of platelets 
and fibrin in the pathogenesis of glomerular injury in the late heterologous phase in 
beige mice. We studied the role of platelets by treating mice with anti-platelet 
antibodies, and the role of fibrin by defibrinogenation with ancrod. Platelet depletion 
did not influence the influx of PMN, neither did it have an effect on the 
morphological damage or the albuminuria of the entire heterologous phase. Although 
defibrinogenation with ancrod resulted in a slight reduction of glomerular PMN 
influx, it had no effect on the morphological damage or the albuminuria. However, 
ancrod treatment did not abolish the deposition of glomerular fibrin, despite 
unmeasurable levels of serum fibrinogen. We conclude that platelets are not essential 
mediators of albuminuria and glomerular damage in the heterologous phase of anti-
GBM nephritis in beige mice. The contribution of fibrin to the glomerular damage 
could, however, not firmly be established, given the inability of ancrod to inhibit the 
glomerular fibrin deposits (chapter 4). 
The role of macrophages in the mediation of glomerular damage has been extensively 
studied in anti-GBM nephritis, particularly in the autologous phase (11). Depletion 
studies using polyclonal antibodies showed that macrophages are not involved in the 
pathogenesis of the heterologous phase in rabbits (12). By using a diet deficient of 
essential fatty acids, a role for macrophages in the heterologous phase in rats was 
suggested (13,14). Since depletion studies are the most elegant and reliable way to 
study the role of the inflammatory cells, we have attempted to produce polyclonal 
and monoclonal antibodies highly selective for macrophages. Despite exhaustive 
attempts we did not succeed in producing a monospecific antibody. All batches 
proved to be cross-reactive with PMN, not an unexpected finding as these cells have 
many membrane epitopes in common. We, therefore, examined the efficacy of an 
alternative depletion method, the liposome mediated macrophage suicide technique 
(15), that has been reported to result in selective and long term elimination of tissue 
macrophages in liver and spleen without exhibiting deleterious effects on other 
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leukocytes. Treatment with liposomes containing dichlorodimethylene 
bisphosphonate (clodro-1) significantly diminished albuminuria and glomerular 
damage in mice 24 hours after administration of anti-GBM antibody. However, it 
also markedly reduced the glomerular influx of PMN at two hours. Since we found in 
earlier studies a direct correlation between the number of glomerular PMN, the 
ensuing albuminuria, and the morphological alterations, we presume that the 
beneficial effect of the liposome treatment seen in this model is probably due to the 
inhibition of the accumulation of PMN in the glomeruli. The mechanism responsible 
for the reduced number of glomerular PMN after liposome treatment is unknown. 
We conclude that treatment with clodro-1 containing liposomes is a valuable method 
of selective macrophage depletion, but has a limited use in PMN dependent models 
of inflammation (chapter 5). 
Besides the heterologous phase of anti-GBM nephritis, the autologous phase has 
frequently been used as a model of glomerular inflammation, in which particularly 
the role of macrophages has been studied (11,16). A variant of this model is the more 
reproducible, so-called accelerated form of the autologous phase, induced by the 
injection of subnephritogenic doses of anti-GBM antibody into rats or rabbits 
preimmunized with normal heterologous immunoglobulin. After linear binding of the 
administered heterologous anti-GBM antibodies to the GBM, immediately followed 
by the linear binding of the host [i.e autologous) antibodies to the heterologous 
immunoglobulin, a mild influx of PMN is seen in the glomeruli, which precedes a 
marked accumulation of macrophages. This influx of inflammatory cells is 
accompanied by massive proteinuria, proliferation of resident glomerular cells, and 
intravascular coagulation, and evolves into a chronic glomerulonephritis with 
extensive sclerosis. There is now ample evidence that not complement, but the 
recruited macrophages are responsible for most of the renal alterations (17, reviewed 
in 18). Which mechanisms are involved in the sequential accumulation of PMN and 
macrophages in the accelerated autologous phase (and in the heterologous phase as 
well) is not well understood. The predominant presence of macrophages in the 
accelerated autologous phase has been explained by the higher affinity of these cells 
for the Fc-fragment of the host immunoglobulin fixed to the GBM (19). An 
additional explanation for the sequential and preferential accumulation of different 
inflammatory cells in the glomeruli may be the different generation of 
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chemoattractants in both phases of anti-GBM nephritis that attract specific cells to 
the glomerulus (20-23). This has nicely been shown for the heterologous and 
accelerated autologous phase of anti-GBM nephritis in the rat (23). The glomerular 
expression of the MIP-2 gene, a chemokine from the ß-subfamily, and MCP-1 gene, 
a chemokine of the α-subfamily, correlated with the sequential influx of PMN and 
monocytes respectively (23). These chemokines influence the expression of several 
adhesion molecules on glomerular and invading cells, which also may direct the 
recruitment of the different inflammatory cells in a sequential way (24-31, reviewed 
in 32). 
In mice preimmunized with heterologous immunoglobulin six to seven days before 
the i.v. administration of a subnephritogenic dose of anti-GBM antibody, we 
succesfully established an accelerated autologous phase of anti-GBM nephritis. 
There was a narrow time window during which the nephritis could be induced. 
Injection of the antibody on day 8 after preimmunization resulted invariably in a 
lethal anaphylactic shock, whereas administration of the antibody on day 5 after 
preimmunization did not lead to an albuminuria nor to morphological damage as 
determined one day after administration. Injection of a subnephritogenic dose of anti-
GBM antibody on day 7 induced a massive albuminuria one day later which slightly 
decreased thereafter. There was a mild influx of PMN in the glomeruli at two hours, 
that gradually decreased during the following days. No increase of glomerular 
macrophages could be observed during the first eight days. Morphological damage 
was severe and characterized by intravascular coagulation, necrosis and proliferation 
of resident glomerular cells with the formation of small crescents. By 
immunofluorescence, both the heterologous and autologous antibodies were observed 
in a linear fashion along the GBM. The amount of fibrin deposits in the glomeruli 
increased during the course of the disease (chapter 6). 
We also examined the role of macrophages and the macrophage related chemokines 
CSF-1, MCP-1 and RANTES in this accelerated model using the op/op mouse, a 
strain of mice that lacks the macrophage chemotactic factor colony stimulating factor 
(CSF-1). This leads to a severe deficiency in blood monocytes and tissue 
macrophages (33). Op/op mice and the (normal) op/+ control mice developed 
comparable albuminuria and morphological damage. MCP-1 and RANTES were 
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expressed in comparable levels in Northern blots of renal tissue from both op, op and 
op,J> mice, while CSF-1 was, as expected, not expressed in op'op mice. Only the 
early PMN accumulation in the glomeruli was found, while the number of 
macrophages was not increased in the op/+ mice and negligible in the op'op mice. 
From these studies we could confirm that the accelerated autologous phase of anti-
GBM nephritis is not dependent on the presence of glomerular macrophages. It 
seems likely that the early PMN influx, like in the heterologous phase, is responsible 
for the induction of the albuminuria and glomerular injury in this model (chapter 7). 
The accelerated autologous phase in mice is thus a reproducible model of 
glomerulonephritis that is complement and macrophage independent. The 
morphological features and the albuminuria resemble those in the heterologous 
phase, but are more severe. This model seems very useful to unravel the role of 
adhesion molecules, cytokines, chemokines, eiconasoids and cellular components by 
using different "knock out" mice or mutant strains. 
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SAMENVATTING 
Bij proefdieren heeft de intraveneuze (i.v.) toediening van heterologe antilichamen 
(d.w.z. antilichamen afkomstig van een andere diersoort) gericht tegen de 
glomerulaire basaal membraan (GBM) tot gevolg dat verschillende humorale en 
cellulaire ontstekingsmediatoren geactiveerd worden, hetgeen leidt tot morfologische 
beschadiging van de glomeruli gepaard gaande met eiwitverlies in de urine. Eerdere 
studies in dit model van passieve anti-GBM nefritis in de muis hebben aangetoond 
dat de albuminurie en de morfologische veranderingen, die ontstaan na i.v. 
toediening van anti-GBM antilichamen, niet afhankelijk zijn van complement 
activatie maar wel van de aanwezigheid van polymorfonucleaire granulocyten 
(PMN) die kunnen reageren met de Fc-fragmenten van de antilichamen. Tevens is 
gebleken dat in beige muizen, die deficiënt zijn voor de leukocytaire neutrale 
Proteinasen elastase en cathepsine G, geen albuminurie ontstaat binnen 24 uur na 
inductie van de nefritis. Dit ondanks het feit dat na toediening van anti-GBM 
antilichamen een influx van PMN en morfologische schade ontstaan vergelijkbaar 
met die in controle muizen, die wel een vroege albuminurie ontwikkelen. Door beige 
muizen, waarvan de PMN een normale produktie van zuurstofradicalen vertonen, 
voor te behandelen met stoffen die zuurstofradicalen wegvangen (scavengers) kon 
aannemelijk worden gemaakt dat zuurstofradicalen niet betrokken zijn bij het 
ontstaan van de albuminurie in de vroege heterologe fase. Dit laatste in tegenstelling 
tot de bevindingen in hetzelfde model in de rat, waarin zuurstofradicalen een centrale 
rol bij het ontstaan van de Proteinurie lijken te spelen. 
Om met zekerheid vast te stellen dat de afwezigheid van albuminurie in de vroege 
heterologe fase in de beige muis het gevolg is van de deficiëntie voor de leukocytaire 
neutrale Proteinasen van de beige PMN en niet van onbekende lokale of systemische 
humorale factoren, die mogelijk alleen in de beige muis aanwezig zouden kunnen 
zijn, voerden we reciproke beenmergtransplantaties uit in C57BL/6J, bg'bg (beige) 
muizen en in de congene, normale C57BL/6J, +/+ muis. Bij beige muizen die 
getransplanteerd werden met beenmerg van normale controle muizen ontstond een 
albuminurie vergelijkbaar aan die van niet-getransplanteerde controle nefritische 
muizen na dezelfde anti-GBM injectie. Reconstitutie van beige beenmerg in 
voorbestraalde controle muizen leidde na i.v. toediening van anti-GBM antilichamen 
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tot een albuminurie die niet boven het niveau van de fysiologische albuminurie van 
beige muizen uitkwam. Syngene (van dezelfde stam) beenmergtransplantatie had 
geen invloed op de albuminurie. In alle groepen werd een identieke glomeralaire 
PMN influx 2 uur na de iv toediening van anti-GBM antilichamen vastgesteld. De 
morfologische schade aan de glomeruli na 24 uur was eveneens vergelijkbaar in alle 
groepen. We concluderen uit deze experimenten dat de intrinsieke afwezigheid van 
de leukocytaire neutrale Proteinasen in de beige PMN verantwoordelijk is voor de 
afwezigheid van de albuminurie in de vroege heterologe fase (hoofdstuk 2). 
De heterologe fase is die periode van de anti-GBM nefritis die veroorzaakt wordt 
door de acrivatie van verschillende ontstekingsmediatoren na binding van de 
toegediende heterologe anti-GBM antilichamen. Deze antilichamen brengen een 
immuunrespons bij de ontvanger teweeg, waarbij na 6 dagen eigen (autologe) 
antistoffen worden gevormd die reageren met de reeds aan de GBM gebonden 
heterologe antistoffen. Als gevolg hiervan worden verschillende ontstekings-
mediatoren geactiveerd (autologe fase). Om de rol van een zich ontwikkelende 
autologe fase met zekerheid uit te sluiten concentreert de studie van de heterologe 
fase zich meestal op de gebeurtenissen in de eerste 24 uur. Aangezien er in beige 
muizen, ondanks een glomerulaire PMN influx na 2 uur en morfologische schade na 
24 uur, die vergelijkbaar is aan die in controle C57BL/6J, +/+ muizen, geen 
albuminurie ontstond, besloten we de gevolgen van de i.v. toediening van anti-GBM 
antilichamen aan beige muizen gedurende een langere periode te bestuderen. Tot 
onze verrassing bleek zich bij beige muizen op dag 2 een albuminurie te ontwikkelen, 
die reeds op dag 3 het niveau van dat in de congene nefritische controle muizen 
bereikte. Deze late albuminurie was complement onafhankelijk en PMN- en Fc-
fragment afhankelijk. Morfologisch werd er geen toename van macrofagen, CD4+ of 
CD8+ lymfocyten waargenomen. De toediening van de scavenger dimethylsulfoxide 
(DMSO) leidde tot een aanzienlijke afname van de albuminurie en de morfologische 
schade, hetgeen wijst op een centrale rol voor zuurstofradicalen bij het ontstaan van 
deze afwijkingen in de late heterologe fase. We concluderen dat de heterologe fase 
een bifasisch verloop kent, waarbij de vroege fase gekenmerkt wordt door een 
albuminurie die afhankelijk is van de leukocytaire neutrale proteïnasen elastase en 
cathepsine G, terwijl de late heterologe fase grotendeels afhankelijk is van 
zuurstofradicalen (hoofdstuk 3). 
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Aangezien in de glomeruli van nefritische muizen forse intravasale stolling vanaf 24 
uur waarneembaar is werd de rol van trombocyten en fibrine in de late heterologe 
fase onderzocht. Trombocyten depletie, geïnduceerd door toediening van een 
polyclonaal antitrombocyten antiserum, had geen invloed op de PMN influx, en 
evenmin op de morfologische schade of de albuminurie. Defibrinatie met ancrod had 
een geringe afname van de PMN influx in de glomeruli tot gevolg, maar had geen 
enkel beschermend effect op albuminurie of morfologische schade. Hierbij moet 
worden aangetekend dat, ondanks onmeetbaar lage fibrinogeen spiegels in het serum 
van de met ancrod behandelde muizen, er toch nog fibrine deposities in de glomeruli 
waarneembaar waren. Voor het ontstaan van de albuminurie en de morfologische 
schade aan de glomeruli zijn trombocyten en waarschijnlijk ook fibrine geen 
essentiële mediatoren (hoofdstuk 4). 
Om de rol van macrofagen in de heterologe fase van de anti-GBM nefritis in de muis 
te bestuderen hebben we getracht specifieke antisera tegen deze cellen te produceren. 
Daar het onmogelijk bleek om antisera te produceren die niet kruis-reageerden met 
PMN en voorlopers daarvan kozen wij voor een andere veelvuldig gebruikte aanpak, 
de z.g. liposoom "suïcide-methode". De i.v. toediening van dichlorodimethyleen 
bisfosfonaat bevattende liposomen (clodro-1) leidt tot een selectieve en langdurige 
depletie van macrofagen in lever en milt. Voorbehandeling met clodro-1 in ons model 
leidde tot een aanzienlijke afname van de albuminurie en de glomerulaire schade 24 
uur na de toediening van anti-GBM antilichamen, zonder van invloed te zijn op het 
aantal glomerulaire macrofagen. Het resulteerde echter ook in een halvering van de 
PMN influx in de glomeruli 2 uur na inductie van de nefritis. Aangezien eerder al is 
aangetoond dat er een directe correlatie is tussen het aantal glomerulaire PMN en de 
daarop volgende albuminurie, veronderstellen we dat de afname van de albuminurie 
veroorzaakt werd door de verminderde PMN influx en niet door een effect van 
clodro-1 op macrofagen. Via welk mechanisme dit geschiedt is onbekend (hoofdstuk 
5). 
Door muizen te preimmuniseren met normaal Immunoglobuline, en na 6 tot 7 dagen 
een subnefritogene dosis anti-GBM antilichamen i.v. toe te dienen, konden we een 
stabiele, reproduceerbare variant van de autologe fase van anti-GBM nefritis 
induceren, de zogenaamde versnelde autologe fase. In deze voorbehandelde muizen 
101 
ontstond direct na de toediening van een lage, subnefritogene dosis anti-GBM 
antilichamen een milde glomerulaire PMN influx en progressieve morfologische 
schade. Na 24 uur werd er een zeer forse albuminurie gemeten, die dagenlang 
aanhield. In dit model van de geaccelereerde autologe fase werd de rol van 
macrofagen en de macrofaag-gerelateerde chemokinen CSF-1, MCP-1 en RANTES 
bij het ontstaan van morfologische schade en albuminurie bestudeerd in de op/op 
muis en de normale, congene op/+ controle muis. Op'op muizen hebben een 
deficiëntie voor CSF-1 hetgeen leidt tot een ernstige deficiëntie van circulerende 
monocyten en weefselmacrofagen. Bij op'op en op/+ muizen ontstond na toediening 
van anti-GBM antilichamen vergelijkbare albuminurie en morfologische schade. In 
Northern blot analyse van nierweefsel bleek dat MCP-1 en RANTES door beide 
muizenstammen in gelijke mate tot expressie werden gebracht, terwijl CSF-1 in de 
op'op muis zoals verwacht niet tot expressie kwam. In beide stammen werd slechts 
een vroege influx van PMN in de glomeruli waargenomen, terwijl het aantal 
glomerulaire macrofagen in de op'4- muizen niet toenam en in de op'op muizen 
verwaarloosbaar klein bleef. Derhalve lijkt ook in de versnelde autologe fase van de 
passieve anti-GBM nefritis van de muis geen rol voor macrofagen weggelegd 
(hoofdstuk 6). 
Het model van de versnelde autologe fase van anti-GBM nefritis in de muis blijkt een 
goed reproduceerbaar model van glomeralonefritis te zijn, dat zich ontwikkelt 
onafhankelijk van complement activatie of macrofaag activiteit. De histologische 
afwijkingen en de albuminurie zijn ernstiger dan die in de heterologe fase. Het 
autologe model lijkt daarom een model dat zeer geschikt is om de betrokkenheid van 
verschillende inflammatoire mediatoren in de ontwikkeling van de glomerulonefritis 
te bestuderen, o.a. van adhesie moleculen, cytokines, chemokines, eiconasoïdenen 
cellulaire componenten. Het muis-model is hiervoor bij uitstek geschikt door de 
beschikbaarheid van verschillende "knock-out" muizen en mutante stammen met hun 
specifieke deficiënties. 
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DANKWOORD 
Het schrijven van een proefschrift is in mijn geval vergelijkbaar met het maken 
van een film: er is een scenario, de financiers zijn gevonden, dan worden de 
spelers bij elkaar gezocht. Dat ik een rol heb kunnen spelen is mede aan mijn 
ouders te danken geweest. 
Een scenario wordt vele malen aangepast. Het uiteindelijk produkt ontstaat op de 
montagetafel waarbij veel materiaal wordt weggeknipt. Bij de definitieve versie 
volgt aan het eind de aftiteling: 
Producent: Prof.dr. Rob Koene. 
(leermeester m de Nefrologie) 
Scenario en regie: dr. Karel Assmann en dr. José Bogman. 
Speciale adviseur: dr. Joost Schalkwijk. 
Special Guest Stars: dr. Joel Neugarten, Prof.dr. Detleff Schlondorff 
en dr. Nico van Rooijen. 
Belangrijkste mannelijke bijrol: Fons van Gompel. 
Adviseurs Fons en Geert: Jacco van Son en Henri Dijkman. 
Technische adviezen en bijstand: Ine Cornelissen. 
Belangrijkste vrouwelijke bijrollen: Ine Dooper en dr. Rose-Marie Termaat. 
Ondersteunende bijrollen (m/v): alle medewerkers van het lab 
Immunopathologie. 
Dierenverzorging: Jan Koedam en medewerkers (m/v). 
Statistiek: dr. Andries Hoitsma. 
Fotografie: Henri Dijkman. 
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Special effects coupes: Oda Wolf, Lambert Burgers en Marian Blokpoel. 
Adviezen: lab. Nefrologie. 
Hematologische scene's: medewerkers van lab Hematologic 
Coaching: Monique Muselaers. 
Vrolijke noot: Sjoerd Watse en Onno Boelo. 
Time-outs: de Schipper en zijn maatjes. 
Met dank aan Prof.dr. Dirk Ruyter voor de gastvrijheid op locatie. 
Financiering: Nierstichting Nederland. 
(Dat velen die, op welke wijze dan ook, bijgedragen hebben aan de tot standkommg van 
dit proefschrift ongenoemd blijven betekent niet dat hun bijdrage niet op waarde wordt 
geschat, integendeel) 
THE END 
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CURRICULUM VITAE 
Geert Watse Feith werd 3 mei 1952 geboren te Leiden. Na het behalen van het 
diploma HBS-B aan het Eindhovens Protestants Lyceum, vervulde hij tussen 
1972 en 1973 de militaire dienstplicht. De studie Geneeskunde werd aan de 
Universiteit van Amsterdam gevolgd, alwaar hij gedurende 5 jaar student-
assistent anatomie was. Na de bevordering tot arts op 6 oktober 1982 werd hij 
opgeleid tot internist in het St Joseph Ziekenhuis, toendertijd te Eindhoven 
(opleiders dr. P.F.L.H.M. Deckers en dr. P.G.G. Gerlag). Op 1 november 1987 
werd hij geregistreerd als internist. Na 14 maanden werkzaam te zijn geweest op 
de afdeling Acute Inwendige Geneeskunde (hoofd Prof.dr. L.G. Thijs) van de 
Vrije Universiteit te Amsterdam, volgde de aanstelling tot internist aan de 
afdeling Nefrologie (hoofd Prof.dr. R.A.P. Koene) van het Academisch 
Ziekenhuis Nijmegen. Daar werd hij in de gelegenheid gesteld zich in de 
nefrologie te bekwamen (registratie in het aandachtsgebied nefrologie in 1994) en 
het in dit proefschrift beschreven onderzoek te verrichten (op het laboratorium 
voor Immunopathologie). Sedert september 1993 is hij als intemist-nefroloog 
werkzaam in het ziekenhuis Gelderse Vallei, voornamelijk op de locatie 
Wageningen. 
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